Donate now
EN FR

Nutrition and Metabolism Branch (NME)

Publications

All recent publications: 2025-2021

 

  1. Aguilera-Buenosvinos I, Morales Berstein F, Gonzalez-Gil EM, Dossus L, Gunter MJ, Biessy C, et al. (2025). Adherence to the Mediterranean Diet and Obesity-Linked Cancer Risk in EPIC. JAMA Netw Open. 8(2): e2461031. https://doi.org/10.1001/jamanetworkopen.2024.61031 PMID: 39998833
  2. Albers FEM, Swain CTV, Lou MWC, Dashti SG, Rinaldi S, Viallon V, et al. (2025). Insulin and Insulin-like Growth Factor and Risk of Postmenopausal Estrogen Receptor-Positive Breast Cancer: A Case-Cohort Analysis. Cancer Epidemiol Biomarkers Prev. 34(4): 541-549. https://doi.org/10.1158/1055-9965.EPI-24-1304 PMID: 39808164
  3. Berger E, Dudouet R, Dossus L, Baglietto L, Gelot A, Boutron-Ruault MC, et al. (2025). Biological embodiment of educational attainment and future risk of breast cancer: findings from a French prospective cohort. BMJ Open. 15(2): e087537. https://doi.org/10.1136/bmjopen-2024-087537 PMID: 39915021
  4. Bohmann P, Stein MJ, Amadou A, Baurecht H, Fervers B, Fontvieille E, et al. (2025). WHO guidelines on waist circumference and physical activity and their joint association with cancer risk. Br J Sports Med. 59(6): 360-366. https://doi.org/10.1136/bjsports-2024-108708 PMID: 39843229
  5. Bohmann P, Stein MJ, Weber A, Konzok J, Fontvieille E, Peruchet-Noray L, et al. (2025). Body Shapes of Multiple Anthropometric Traits and All-cause and Cause-specific Mortality in the UK Biobank. Epidemiology. 36(2): 264-274. https://doi.org/10.1097/EDE.0000000000001810 PMID: 39887119
  6. Chalitsios CV, Markozannes G, Papagiannopoulos C, Aglago EK, Berndt SI, Buchanan DD, et al. (2025). Waist Circumference, a Body Shape Index, and Molecular Subtypes of Colorectal Cancer: A Pooled Analysis of Four Cohort Studies. Cancer Epidemiol Biomarkers Prev. 34(4): 568-577. https://doi.org/10.1158/1055-9965.EPI-24-1534 PMID: 39898780
  7. Chan WC, Liu L, Bouras E, Zuber V, Wen W, Long J, et al. (2025). Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study. Br J Cancer. 132(1): 103-110. https://doi.org/10.1038/s41416-024-02900-7 PMID: 39580580
  8. Chen J, Sun Y, Dan L, Wellens J, Yuan S, Yang H, et al. (2025). Composition of plant-based diets and the incidence and prognosis of inflammatory bowel disease: a multinational retrospective cohort study. Lancet Reg Health Eur. 52: 101264. https://doi.org/10.1016/j.lanepe.2025.101264 PMID: 40166364
  9. Chimera B, Hoobler R, Deschasaux-Tanguy M, Van Merris E, Roels O, Playdon M, et al. (2025). The gut microbiome and eating behavior outcomes: A systematic review. Obes Rev. 26(4): e13880. https://doi.org/10.1111/obr.13880 PMID: 39667924
  10. Colombo GE, Mahamat-Saleh Y, Armour M, Madan K, Sabag A, Kvaskoff M, et al. (2025). Non-malignant gynaecological disease and risk of cardiovascular or cerebrovascular disease: a systematic review and meta-analysis. Heart. 111(9): 402-411. https://doi.org/10.1136/heartjnl-2024-324675 PMID: 39993911
  11. Damerell V, Klaassen-Dekker N, Brezina S, Ose J, Ulvik A, van Roekel EH, et al. (2025). Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer. Int J Cancer. 156(3): 552-565. https://doi.org/10.1002/ijc.35183 PMID: 39308420
  12. Davila-Batista V, Viallon V, Fontvieille E, Jansana A, Kohls M, Bondonno NP, et al. (2025). Associations between cardiometabolic comorbidities and mortality in adults with cancer: multinational cohort study. BMJ Med. 4(1): e000909. https://doi.org/10.1136/bmjmed-2024-000909 PMID: 40151205
  13. Dimopoulou O, Fuller H, Richmond RC, Bouras E, Hayes B, Dimou N, et al. (2025). Mendelian randomization study of sleep traits and risk of colorectal cancer. Sci Rep. 15(1): 13478. https://doi.org/10.1038/s41598-024-83693-w PMID: 40251235
  14. Gonzalez-Gil EM, Matta M, Morales Berstein F, Cairat M, Nicolas G, Blanco J, et al. (2025). Associations between degree of food processing and all-cause and cause-specific mortality: a multicentre prospective cohort analysis in 9 European countries. Lancet Reg Health Eur. 50: 101208. https://doi.org/10.1016/j.lanepe.2024.101208 PMID: 39867840
  15. Grenville ZS, Noor U, Rinaldi S, Gunter MJ, Ferrari P, Agnoli C, et al. (2025). Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 156(5): 943-952. https://doi.org/10.1002/ijc.35208 PMID: 39378119
  16. Karra P, Hardikar S, Winn M, Anderson GL, Haaland B, Shadyab AH, et al. (2025). Metabolic Phenotype and Risk of Obesity-Related Cancers in the Women’s Health Initiative. Cancer Prev Res (Phila). 18(2): 63-72. https://doi.org/10.1158/1940-6207.CAPR-24-0082 PMID: 39540294
  17. Konieczna J, Chaplin A, Paz-Graniel I, Croker H, Becerra-Tomas N, Markozannes G, et al. (2025). Adulthood dietary and lifestyle patterns and risk of breast cancer: Global Cancer Update Programme (CUP Global) systematic literature review. Am J Clin Nutr. 121(1): 14-31. https://doi.org/10.1016/j.ajcnut.2024.10.003 PMID: 39489901
  18. Lamchabbek N, Elattabi C, Bour A, Chimera B, Boutayeb S, Belyamani L, et al. (2025). Associations Between Dietary Factors and Breast Cancer Risk: A Systematic Review of Evidence from the MENA Region. Nutrients. 17(3). https://doi.org/10.3390/nu17030394 PMID: 39940252
  19. Lee MA, Burley KL, Hazelwood EL, Moore S, Lewis SJ, Goudswaard LJ (2025). Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study. Sci Rep. 15(1): 3752. https://doi.org/10.1038/s41598-025-86222-5 PMID: 39885253
  20. Mandle HB, Jenab M, Gunter MJ, Tjonneland A, Olsen A, Dahm CC, et al. (2025). Inflammation and gut barrier function-related genes and colorectal cancer risk in western European populations. Mutagenesis. 40(1): 48-60. https://doi.org/10.1093/mutage/geae008 PMID: 38441165
  21. Onwuka JU, Zahed H, Feng X, Alcala K, Erhunmwunsee L, Williams RM, et al. (2025). Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study. EClinicalMedicine. 82: 103152. https://doi.org/10.1016/j.eclinm.2025.103152 PMID: 40212049
  22. Oyelere AM, Verstraete FF, Kok DE, Bos D, Gunter MJ, de Wilt JHW, et al. (2025). Coffee consumption and mortality in colorectal cancer patients: Does the co-existence of cardiometabolic disease matter? Clin Nutr ESPEN. 67: 62-70. https://doi.org/10.1016/j.clnesp.2025.02.025 PMID: 40057276
  23. Papadimitriou N, Kazmi N, Tsilidis KK, Richmond RC, Lynch BM, Bendinelli B, et al. (2025). Identifying Metabolomic Mediators of the Physical Activity and Colorectal Cancer Relationship. Cancer Epidemiol Biomarkers Prev. 34(4): 578-587. https://doi.org/10.1158/1055-9965.EPI-24-1390 PMID: 39883068
  24. Papadimitriou N, Murphy N, Jenab M, Chen Z, Brenner H, Kweon SS, et al. (2025). Body mass index at birth and early life and colorectal cancer: A two-sample Mendelian randomization analysis in European and East Asian genetic similarity populations. Pediatr Obes. 20(1): e13186. https://doi.org/10.1111/ijpo.13186 PMID: 39587448
  25. Papier K, Bradbury KE, Balkwill A, Barnes I, Smith-Byrne K, Gunter MJ, et al. (2025). Diet-wide analyses for risk of colorectal cancer: prospective study of 12,251 incident cases among 542,778 women in the UK. Nat Commun. 16(1): 375. https://doi.org/10.1038/s41467-024-55219-5 PMID: 39779669
  26. Payen de la Garanderie M, Hasenbohler A, Dechamp N, Javaux G, Szabo de Edelenyi F, Agaesse C, et al. (2025). Food additive mixtures and type 2 diabetes incidence: Results from the NutriNet-Sante prospective cohort. PLoS Med. 22(4): e1004570. https://doi.org/10.1371/journal.pmed.1004570 PMID: 40198579
  27. Peruchet-Noray L, Dimou N, Cordova R, Fontvieille E, Jansana A, Gan Q, et al. (2025). Nature or nurture: genetic and environmental predictors of adiposity gain in adults. EBioMedicine. 111: 105510. https://doi.org/10.1016/j.ebiom.2024.105510 PMID: 39689375
  28. Praud D, Amadou A, Coudon T, Duboeuf M, Mercoeur B, Faure E, et al. (2025). Association between chronic long-term exposure to airborne dioxins and breast cancer. Int J Hyg Environ Health. 263: 114489. https://doi.org/10.1016/j.ijheh.2024.114489 PMID: 39579601
  29. Reichmann R, Nimptsch K, Pischon T, Gunter MJ, Jenab M, Eriksen AK, et al. (2025). Sex- and site-specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort. Int J Cancer. 156(5): 930-942. https://doi.org/10.1002/ijc.35205 PMID: 39511728
  30. Sahrai MS, Dossus L, Biessy C, Rinaldi S, Ferrari P, Wasiq AW, et al. (2025). Dietary patterns among Afghan adults and their associations with overweight and obesity: a cross-sectional study in Kandahar, Afghanistan. BMC Public Health. 25(1): 595. https://doi.org/10.1186/s12889-025-21775-8 PMID: 39948468
  31. Shi F, Chowdhury R, Sofianopoulou E, Koulman A, Sun L, Steur M, et al. (2025). Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospective cohorts and updated meta-analysis. Eur J Prev Cardiol. 32(3): 233-246. https://doi.org/10.1093/eurjpc/zwae315 PMID: 39365172
  32. Thomas CE, Lin Y, Kim M, Kawaguchi ES, Qu C, Um CY, et al. (2025). Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk. Epidemiology. 36(1): 126-138. https://doi.org/10.1097/EDE.0000000000001795 PMID: 39316822
  33. Abbad-Gomez D, Domingo L, Comas M, Santia P, Jansana A, Poblador B, et al. (2024). Effect of comorbidity and multimorbidity on adherence to follow-up recommendations among long-term breast cancer survivors. Maturitas. 182: 107918. https://doi.org/10.1016/j.maturitas.2024.107918 PMID: 38280353
  34. Aglago EK, Qu C, Harlid S, Phipps AI, Steinfelder RS, Ogino S, et al. (2024). Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. Am J Clin Nutr. 120(3): 664-673. https://doi.org/10.1016/j.ajcnut.2024.07.012 PMID: 39025327
  35. Albers FEM, Lou MWC, Dashti SG, Swain CTV, Rinaldi S, Viallon V, et al. (2024). Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis. Cancer Causes Control. 35(6): 921-933. https://doi.org/10.1007/s10552-024-01856-6 PMID: 38363402
  36. Amadou A, Freisling H, Sedlmeier AM, Bohmann P, Fontvieille E, Weber A, et al. (2024). Multi-Trait Body Shape Phenotypes and Breast Cancer Risk in Postmenopausal Women: A Causal Mediation Analysis in the UK Biobank Cohort. J Epidemiol Glob Health. 14(2): 420-432. https://doi.org/10.1007/s44197-024-00226-4 PMID: 38598163
  37. Antoniussen CS, Proust-Lima C, Ibsen DB, Olsen A, Overvad K, Tjonneland A, et al. (2024). Alcohol consumption trajectories and risk of breast cancer among postmenopausal women: a Danish cohort study. Eur J Epidemiol. 39(12): 1353-1362. https://doi.org/10.1007/s10654-024-01179-5 PMID: 39630402
  38. Beigrezaei S, Dianati M, Salehi-Abargouei A, Fararouei M, Akbari-Beni A, Brinkman M, et al. (2024). The association between animal protein, plant protein, and their substitution with bladder cancer risk: a pooled analysis of 10 cohort studies. Eur J Nutr. 64(1): 55. https://doi.org/10.1007/s00394-024-03551-3 PMID: 39718625
  39. Berger E, Gelot A, Fournier A, Dossus L, Boutron-Ruault MC, Severi G, et al. (2024). Educational level and characteristics of invasive breast cancer: findings from a French prospective cohort. Cancer Causes Control. 35(8): 1151-1163. https://doi.org/10.1007/s10552-024-01873-5 PMID: 38615276
  40. Boden S, Zheng R, Ribbenstedt A, Landberg R, Harlid S, Vidman L, et al. (2024). Dietary patterns, untargeted metabolite profiles and their association with colorectal cancer risk. Sci Rep. 14(1): 2244. https://doi.org/10.1038/s41598-023-50567-6 PMID: 38278865
  41. Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G, Heath AK, et al. (2024). Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol. 39(2): 147-159. https://doi.org/10.1007/s10654-023-01059-4 PMID: 38180593
  42. Breeur M, Stepaniants G, Keski-Rahkonen P, Rigollet P, Viallon V (2024). Optimal transport for automatic alignment of untargeted metabolomic data. Elife. 12: 43. https://doi.org/10.7554/eLife.91597 PMID: 38896449
  43. Bull CJ, Hazelwood E, Legge DN, Corbin LJ, Richardson TG, Lee M, et al. (2024). Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine. 100: 104977. https://doi.org/10.1016/j.ebiom.2024.104977 PMID: 38290287
  44. Cacau LT, Hanley-Cook GT, Vandevijvere S, Leclercq C, De Henauw S, Santaliestra-Pasias A, et al. (2024). Association between adherence to the EAT-Lancet sustainable reference diet and cardiovascular health among European adolescents: the HELENA study. Eur J Clin Nutr. 78(3): 202-208. https://doi.org/10.1038/s41430-023-01379-4 PMID: 38093098
  45. Cairat M, Huybrechts I, Fournier A (2024). Exposure assessment of titanium dioxide via drugs available on the French market: A nationwide descriptive study. Therapie. 79(6): 718-729. https://doi.org/10.1016/j.therap.2024.07.005 PMID: 39174454
  46. Cairat M, Yammine S, Fiolet T, Fournier A, Boutron-Ruault MC, Laouali N, et al. (2024). Degree of food processing and breast cancer risk: a prospective study in 9 European countries. Food Prod Process Nutr. 6(1): 89. https://doi.org/10.1186/s43014-024-00264-2 PMID: 39399144
  47. Castro-Espin C, Cairat M, Navionis AS, Dahm CC, Antoniussen CS, Tjonneland A, et al. (2024). Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival: evidence from the EPIC cohort study. Br J Cancer. 131(9): 1496-1505. https://doi.org/10.1038/s41416-024-02858-6 PMID: 39342063
  48. Chan DSM, Cariolou M, Markozannes G, Balducci K, Vieira R, Kiss S, et al. (2024). Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. Int J Cancer. 155(3): 445-470. https://doi.org/10.1002/ijc.34906 PMID: 38692645
  49. Chang K, Parnham JC, Rauber F, Levy RB, Huybrechts I, Gunter MJ, et al. (2024). Plant-based dietary patterns and ultra-processed food consumption: a cross-sectional analysis of the UK Biobank. EClinicalMedicine. 78: 102931. https://doi.org/10.1016/j.eclinm.2024.102931 PMID: 39619237
  50. Chen Z, Guo X, Tao R, Huyghe JR, Law PJ, Fernandez-Rozadilla C, et al. (2024). Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes. Nat Commun. 15(1): 3557. https://doi.org/10.1038/s41467-024-47399-x PMID: 38670944
  51. Cheng SL, Hedges M, Keski-Rahkonen P, Chatziioannou AC, Scalbert A, Chung KF, et al. (2024). Multiomic Signatures of Traffic-Related Air Pollution in London Reveal Potential Short-Term Perturbations in Gut Microbiome-Related Pathways. Environ Sci Technol. 58(20): 8771-8782. https://doi.org/10.1021/acs.est.3c09148 PMID: 38728551
  52. Cheng SL, Hedges M, Keski-Rahkonen P, Chatziioannou AC, Scalbert A, Chung KF, et al. (2024). Correction to “Multiomic Signatures of Traffic-Related Air Pollution in London Reveal Potential Short-Term Perturbations in Gut Microbiome-Related Pathways”. Environ Sci Technol. 58(39): 17520-17521. https://doi.org/10.1021/acs.est.4c09132 PMID: 39283711
  53. Cheng TS, Noor U, Watts E, Pollak M, Wang Y, McKay J, et al. (2024). Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition. BMC Cancer. 24(1): 676. https://doi.org/10.1186/s12885-023-11425-w PMID: 38831273
  54. Collaborators GBDNSD (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 23(4): 344-381. https://doi.org/10.1016/S1474-4422(24)00038-3 PMID: 38493795
  55. Constantinescu AE, Bull CJ, Jones N, Mitchell R, Burrows K, Dimou N, et al. (2024). Circulating white blood cell traits and colorectal cancer risk: A Mendelian randomisation study. Int J Cancer. 154(1): 94-103. https://doi.org/10.1002/ijc.34691 PMID: 37578112
  56. Damasco-Avila E, Ubico P, Blanco J, Perez M, Farncombe T, Morales G, et al. (2024). The Nutritional Burden of Cancer: Nutritional Status and Body Composition Differences Between Children with Acute Lymphoblastic Leukemia and their Siblings in Guatemala. Nutr Cancer. 76(10): 994-1000. https://doi.org/10.1080/01635581.2024.2382391 PMID: 39033402
  57. Daniel N, Farinella R, Chatziioannou AC, Jenab M, Mayen AL, Rizzato C, et al. (2024). Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study. Sci Rep. 14(1): 25144. https://doi.org/10.1038/s41598-024-77431-5 PMID: 39448785
  58. Daniel N, Farinella R, Chatziioannou AC, Jenab M, Mayen AL, Rizzato C, et al. (2024). Publisher Correction: Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study. Sci Rep. 14(1): 30569. https://doi.org/10.1038/s41598-024-83618-7 PMID: 39702435
  59. Daniel N, Genua F, Jenab M, Mayen AL, Chrysovalantou Chatziioannou A, Keski-Rahkonen P, et al. (2024). The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology. 80(5): 1252-1269. https://doi.org/10.1097/HEP.0000000000000406 PMID: 37055022
  60. de Souza JS, Kliemann N, Vieira FGK, Al Nahas A, Reitz LK, Aglago EK, et al. (2024). Development, Content Validity and Usability of a Self-Assessment Instrument for the Lifestyle of Breast Cancer Survivors in Brazil. Nutrients. 16(21). https://doi.org/10.3390/nu16213707 PMID: 39519541
  61. Debras C, Cordova R, Mayen AL, Maasen K, Knaze V, Eussen S, et al. (2024). Dietary intake of dicarbonyl compounds and changes in body weight over time in a large cohort of European adults. Br J Nutr. 131(11): 1902-1914. https://doi.org/10.1017/S0007114524000503 PMID: 38383991
  62. Deschasaux-Tanguy M, Huybrechts I, Julia C, Hercberg S, Sarda B, Fialon M, et al. (2024). Nutritional quality of diet characterized by the Nutri-Score profiling system and cardiovascular disease risk: a prospective study in 7 European countries. Lancet Reg Health Eur. 46: 101006. https://doi.org/10.1016/j.lanepe.2024.101006 PMID: 39529812
  63. Dicken SJ, Dahm CC, Ibsen DB, Olsen A, Tjonneland A, Louati-Hajji M, et al. (2024). Food consumption by degree of food processing and risk of type 2 diabetes mellitus: a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC). Lancet Reg Health Eur. 46: 101043. https://doi.org/10.1016/j.lanepe.2024.101043 PMID: 39529810
  64. Downham L, Jaafar I, Rol ML, Nyawira Nyaga V, Valls J, Baena A, et al. (2024). Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis. Br J Cancer. 130(4): 517-525. https://doi.org/10.1038/s41416-023-02490-w PMID: 37973957
  65. Drew DA, Kim AE, Lin Y, Qu C, Morrison J, Lewinger JP, et al. (2024). Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. Sci Adv. 10(22): eadk3121. https://doi.org/10.1126/sciadv.adk3121 PMID: 38809988
  66. Fiolet T, Nicolas G, Casagrande C, Horvath Z, Frenoy P, Weiderpass E, et al. (2024). Dietary intakes of dioxins and polychlorobiphenyls (PCBs) and mortality: EPIC cohort study in 9 European countries. Int J Hyg Environ Health. 255: 114287. https://doi.org/10.1016/j.ijheh.2023.114287 PMID: 37989047
  67. Freisling H, Cordova R, Aune D, Wagner KH (2024). Ultra processed foods and cancer-authors’ reply. Lancet Reg Health Eur. 38: 100865. https://doi.org/10.1016/j.lanepe.2024.100865 PMID: 38375449
  68. Gil-Lespinard M, Almanza-Aguilera E, Castaneda J, Guinon-Fort D, Eriksen AK, Tjonneland A, et al. (2024). Plasma Concentration of 36 (Poly)phenols and Prospective Body Weight Change in Participants from the EPIC Cohort. Ann Nutr Metab. 80(2): 87-100. https://doi.org/10.1159/000535803 PMID: 38272006
  69. Goerdten J, Muli S, Rattner J, Merdas M, Achaintre D, Yuan L, et al. (2024). Identification and Replication of Urine Metabolites Associated With Short-Term and Habitual Intake of Sweet and Fatty Snacks in European Children and Adolescents. J Nutr. 154(11): 3274-3285. https://doi.org/10.1016/j.tjnut.2024.09.026 PMID: 39332769
  70. Gonzalez-Gil EM, Peruchet-Noray L, Sedlmeier AM, Christakoudi S, Biessy C, Navionis AS, et al. (2024). Association of body shape phenotypes and body fat distribution indexes with inflammatory biomarkers in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank. BMC Med. 22(1): 334. https://doi.org/10.1186/s12916-024-03544-3 PMID: 39148045
  71. Groninger M, Sabin J, Kaaks R, Amiano P, Aune D, Castro NC, et al. (2024). Associations of milk, dairy products, calcium and vitamin D intake with risk of developing Parkinson s disease within the EPIC4ND cohort. Eur J Epidemiol. 39(11): 1251-1265. https://doi.org/10.1007/s10654-024-01183-9 PMID: 39625618
  72. Harewood R, Rothwell JA, Besevic J, Viallon V, Achaintre D, Gicquiau A, et al. (2024). Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). EBioMedicine. 101: 105024. https://doi.org/10.1016/j.ebiom.2024.105024 PMID: 38412638
  73. Hawwash NK, Sperrin M, Martin GP, Sinha R, Matthews CE, Ricceri F, et al. (2024). Excess weight by degree and duration and cancer risk (ABACus2 consortium): a cohort study and individual participant data meta-analysis. EClinicalMedicine. 78: 102921. https://doi.org/10.1016/j.eclinm.2024.102921 PMID: 39640936
  74. Hazelwood E, Lopez Manzano C, Vincent EE, Albanes D, Bishop DT, Le Marchand L, et al. (2024). Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis. Cancer Epidemiol Biomarkers Prev. 33(12): 1727-1732. https://doi.org/10.1158/1055-9965.EPI-24-0926 PMID: 39361354
  75. His M, Gunter MJ, Keski-Rahkonen P, Rinaldi S (2024). Application of Metabolomics to Epidemiologic Studies of Breast Cancer: New Perspectives for Etiology and Prevention. J Clin Oncol. 42(1): 103-115. https://doi.org/10.1200/JCO.22.02754 PMID: 37944067
  76. Huybrechts I, Chimera B, Hanley-Cook GT, Biessy C, Deschasaux-Tanguy M, Touvier M, et al. (2024). Food biodiversity and gastrointestinal cancer risk in nine European countries: Analysis within a prospective cohort study. Eur J Cancer. 210: 114258. https://doi.org/10.1016/j.ejca.2024.114258 PMID: 39168001
  77. Huybrechts I, Jacobs I, Biessy C, Aglago EK, Jenab M, Claeys L, et al. (2024). Associations between dietary mycotoxins exposures and risk of hepatocellular carcinoma in a European cohort. PLoS One. 19(12): e0315561. https://doi.org/10.1371/journal.pone.0315561 PMID: 39680546
  78. Jansana A, Auguste A, Kvaskoff M, Fournier A, Fontvieille E, Peruchet-Noray L, et al. (2024). Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study. Cancer Commun (Lond). 44(5): 593-597. https://doi.org/10.1002/cac2.12526 PMID: 38487965
  79. Jenkins DJA, Willett WC, Yusuf S, Hu FB, Glenn AJ, Liu S, et al. (2024). Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants. Lancet Diabetes Endocrinol. 12(2): 107-118. https://doi.org/10.1016/S2213-8587(23)00344-3 PMID: 38272606
  80. Johansson H, Bellerba F, Macis D, Bertelsen BE, Guerrieri-Gonzaga A, Aristarco V, et al. (2024). Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials. Breast Cancer Res Treat. 205(1): 49-59. https://doi.org/10.1007/s10549-023-07241-2 PMID: 38279016
  81. Khalis M, Elbadisy I, Bouaddi O, Luo A, Bendriouich A, Addahri B, et al. (2024). Cluster analysis of cancer knowledge, attitudes and behaviors in the Moroccan population. BMC Cancer. 24(1): 669. https://doi.org/10.1186/s12885-024-12226-5 PMID: 38824496
  82. Klont F, Nijdam FB, Bakker SJL, Keski-Rahkonen P, Hopfgartner G, Investigators T (2024). High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. Analyst. 149(4): 1061-1067. https://doi.org/10.1039/d3an01874a PMID: 38251754
  83. Landberg R, Karra P, Hoobler R, Loftfield E, Huybrechts I, Rattner JI, et al. (2024). Dietary biomarkers-an update on their validity and applicability in epidemiological studies. Nutr Rev. 82(9): 1260-1280. https://doi.org/10.1093/nutrit/nuad119 PMID: 37791499
  84. Laskar RS, Qu C, Huyghe JR, Harrison T, Hayes RB, Cao Y, et al. (2024). Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer. Ann Oncol. 35(6): 523-536. https://doi.org/10.1016/j.annonc.2024.02.008 PMID: 38408508
  85. Lee MA, Hatcher CA, Hazelwood E, Goudswaard LJ, Tsilidis KK, Vincent EE, et al. (2024). A proteogenomic analysis of the adiposity colorectal cancer relationship identifies GREM1 as a probable mediator. Int J Epidemiol. 54(1): 13. https://doi.org/10.1093/ije/dyae175 PMID: 39846783
  86. Li J, Roshelli Baker J, Aglago EK, Zhao Z, Jiao L, Freisling H, et al. (2024). Pre-diagnostic plasma advanced glycation end-products and soluble receptor for advanced glycation end-products and mortality in colorectal cancer patients. Int J Cancer. 155(11): 1982-1995. https://doi.org/10.1002/ijc.35114 PMID: 39057841
  87. Li M, Cao SM, Dimou N, Wu L, Li JB, Yang J (2024). Association of Metabolic Syndrome With Risk of Lung Cancer: A Population-Based Prospective Cohort Study. Chest. 165(1): 213-223. https://doi.org/10.1016/j.chest.2023.08.003 PMID: 37572975
  88. Lopez-Jimenez T, Plana-Ripoll O, Duarte-Salles T, Recalde M, Bennett M, Xavier-Cos F, et al. (2024). Exploring the association between metabolic syndrome, its components and subsequent cancer incidence: A cohort study in Catalonia. Cancer Med. 13(16): e7400. https://doi.org/10.1002/cam4.7400 PMID: 39149842
  89. Mahamat-Saleh Y, Aune D, Freisling H, Hardikar S, Jaafar R, Rinaldi S, et al. (2024). Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies. Br J Cancer. 131(9): 1480-1495. https://doi.org/10.1038/s41416-024-02857-7 PMID: 39317703
  90. Markozannes G, Becerra-Tomas N, Cariolou M, Balducci K, Vieira R, Kiss S, et al. (2024). Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. Int J Cancer. 155(3): 426-444. https://doi.org/10.1002/ijc.34903 PMID: 38692650
  91. Matta K, Viallon V, Botteri E, Peveri G, Dahm C, Nannsen AO, et al. (2024). Healthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort. BMC Med. 22(1): 210. https://doi.org/10.1186/s12916-024-03362-7 PMID: 38807179
  92. Mayen AL, Sabra M, Aglago EK, Perlemuter G, Voican C, Ramos I, et al. (2024). Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study. BMC Med. 22(1): 221. https://doi.org/10.1186/s12916-024-03366-3 PMID: 38825687
  93. Meyer A, Dong C, Chan SSM, Touvier M, Julia C, Huybrechts I, et al. (2024). Dietary index based on the Food Standards Agency nutrient profiling system and risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 59(4): 558-568. https://doi.org/10.1111/apt.17835 PMID: 38100159
  94. Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hemon B, et al. (2024). Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis. Eur J Nutr. 63(2): 377-396. https://doi.org/10.1007/s00394-023-03270-1 PMID: 37989797
  95. Mori N, Murphy N, Sawada N, Achaintre D, Yamaji T, Scalbert A, et al. (2024). Reproducibility and dietary correlates of plasma polyphenols in the JPHC-NEXT Protocol Area study. Eur J Clin Nutr. 78(1): 34-42. https://doi.org/10.1038/s41430-023-01349-w PMID: 37891229
  96. Muli S, Blumenthal A, Conzen CA, Benz ME, Alexy U, Schmid M, et al. (2024). Association of Ultraprocessed Foods Intake with Untargeted Metabolomics Profiles in Adolescents and Young Adults in the DONALD Cohort Study. J Nutr. 154(11): 3255-3265. https://doi.org/10.1016/j.tjnut.2024.09.023 PMID: 39332770
  97. Muli S, Schnermann ME, Merdas M, Rattner J, Achaintre D, Perrar I, et al. (2024). Metabolomics signatures of sweetened beverages and added sugar are related to anthropometric measures of adiposity in young individuals: results from a cohort study. Am J Clin Nutr. 120(4): 879-890. https://doi.org/10.1016/j.ajcnut.2024.07.021 PMID: 39059709
  98. Noh H, Anota A, Mongondry R, Meyrand R, Dupuis C, Schiffler C, et al. (2024). Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial. BMC Cancer. 24(1): 84. https://doi.org/10.1186/s12885-024-11824-7 PMID: 38225551
  99. Noh H, Lee J, Seyed Khoei N, Peruchet-Noray L, Kang D, Fervers B, et al. (2024). Serum bilirubin levels and risk of colorectal cancer in Korean adults: results from the Korean Genome and Epidemiology Study-Health Examinee (KoGES-HEXA) Cohort Study. Br J Cancer. 131(10): 1635-1643. https://doi.org/10.1038/s41416-024-02847-9 PMID: 39379570
  100. O’Grady TJ, Rinaldi S, Michels KA, Adami HO, Buring JE, Chen Y, et al. (2024). Association of hormonal and reproductive factors with differentiated thyroid cancer risk in women: a pooled prospective cohort analysis. Int J Epidemiol. 53(1). https://doi.org/10.1093/ije/dyad172 PMID: 38110618
  101. Oyelere AM, Kok DE, Bos D, Gunter MJ, Ferrari P, Keski-Rahkonen P, et al. (2024). Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all-cause mortality. Int J Cancer. 154(12): 2054-2063. https://doi.org/10.1002/ijc.34879 PMID: 38346920
  102. Papadimitriou N, Kazmi N, Dimou N, Tsilidis KK, Martin RM, Lewis SJ, et al. (2024). Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis. Cancer Med. 13(1): e6732. https://doi.org/10.1002/cam4.6732 PMID: 38155458
  103. Papadimitriou N, Kim A, Kawaguchi ES, Morrison J, Diez-Obrero V, Albanes D, et al. (2024). Genome-wide interaction study of dietary intake of fibre, fruits, and vegetables with risk of colorectal cancer. EBioMedicine. 104: 105146. https://doi.org/10.1016/j.ebiom.2024.105146 PMID: 38749303
  104. Papadimitriou N, Qu C, Harrison TA, Bever AM, Martin RM, Tsilidis KK, et al. (2024). Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses. EBioMedicine. 101: 105010. https://doi.org/10.1016/j.ebiom.2024.105010 PMID: 38350331
  105. Peruchet-Noray L, Sedlmeier AM, Dimou N, Baurecht H, Fervers B, Fontvieille E, et al. (2024). Tissue-specific genetic variation suggests distinct molecular pathways between body shape phenotypes and colorectal cancer. Sci Adv. 10(16): eadj1987. https://doi.org/10.1126/sciadv.adj1987 PMID: 38640244
  106. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Wu K, et al. (2024). Pre-diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer. 154(9): 1596-1606. https://doi.org/10.1002/ijc.34830 PMID: 38200695
  107. Rauber F, Laura da Costa Louzada M, Chang K, Huybrechts I, Gunter MJ, Monteiro CA, et al. (2024). Implications of food ultra-processing on cardiovascular risk considering plant origin foods: an analysis of the UK Biobank cohort. Lancet Reg Health Eur. 43: 100948. https://doi.org/10.1016/j.lanepe.2024.100948 PMID: 39210945
  108. Ren X, Nicolas G, Frenoy P, Papier K, Moreno-Iribas C, Masala G, et al. (2024). Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC) cohort. Diabetes Metab. 50(6): 101587. https://doi.org/10.1016/j.diabet.2024.101587 PMID: 39521120
  109. Rinaldi S, Dossus L, Keski-Rahkonen P, Kiss A, Navionis AS, Biessy C, et al. (2024). Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women. Int J Cancer. 154(12): 2064-2074. https://doi.org/10.1002/ijc.34872 PMID: 38357914
  110. Rontogianni MO, Bouras E, Aglago EK, Freisling H, Murphy N, Cotterchio M, et al. (2024). Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis. Int J Obes (Lond). 48(5): 709-716. https://doi.org/10.1038/s41366-024-01479-6 PMID: 38297030
  111. Salame C, Javaux G, Sellem L, Viennois E, de Edelenyi FS, Agaesse C, et al. (2024). Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Sante prospective cohort study. Lancet Diabetes Endocrinol. 12(5): 339-349. https://doi.org/10.1016/S2213-8587(24)00086-X PMID: 38663950
  112. Sellem L, Srour B, Javaux G, Chazelas E, Chassaing B, Viennois E, et al. (2024). Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Sante cohort. PLoS Med. 21(2): e1004338. https://doi.org/10.1371/journal.pmed.1004338 PMID: 38349899
  113. Senkin S, Moody S, Diaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013): 910-918. https://doi.org/10.1038/s41586-024-07368-2 PMID: 38693263
  114. Seyyedsalehi MS, Hadji M, Collatuzzo G, Rashidian H, Sasanfar B, Huybrechts I, et al. (2024). Role of dietary intake of specific polyunsaturated fatty acids (PUFAs) on colorectal cancer risk in Iran. Lipids. 59(2): 41-53. https://doi.org/10.1002/lipd.12386 PMID: 38287648
  115. Sohi I, Rehm J, Saab M, Virmani L, Franklin A, Sanchez G, et al. (2024). Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies. Alcohol Clin Exp Res (Hoboken). 48(12): 2222-2241. https://doi.org/10.1111/acer.15493 PMID: 39581746
  116. Stein MJ, Baurecht H, Bohmann P, Fervers B, Fontvieille E, Freisling H, et al. (2024). Diurnal timing of physical activity and risk of colorectal cancer in the UK Biobank. BMC Med. 22(1): 399. https://doi.org/10.1186/s12916-024-03632-4 PMID: 39289682
  117. Stepien M, Duarte-Salles T, Fedirko V, Trichopoulou A, Lagiou P, Bamia C, et al. (2024). Correction to: Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. Eur J Nutr. 63(4): 1389-1391. https://doi.org/10.1007/s00394-024-03374-2 PMID: 38630305
  118. Stern MC, Sanchez Mendez J, Kim AE, Obon-Santacana M, Moratalla-Navarro F, Martin V, et al. (2024). Genome-Wide Gene-Environment Interaction Analyses to Understand the Relationship between Red Meat and Processed Meat Intake and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 33(3): 400-410. https://doi.org/10.1158/1055-9965.EPI-23-0717 PMID: 38112776
  119. Thomas CE, Georgeson P, Qu C, Steinfelder RS, Buchanan DD, Song M, et al. (2024). Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature. Cancer Epidemiol Biomarkers Prev. 33(4): 534-546. https://doi.org/10.1158/1055-9965.EPI-23-0600 PMID: 38252034
  120. Tian Y, Lin Y, Qu C, Arndt V, Baurley JW, Berndt SI, et al. (2024). Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk. Br J Cancer. 130(10): 1687-1696. https://doi.org/10.1038/s41416-024-02638-2 PMID: 38561434
  121. Timmins IR, Jones ME, O’Brien KM, Adami HO, Aune D, Baglietto L, et al. (2024). International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. J Clin Oncol. 42(8): 927-939. https://doi.org/10.1200/JCO.23.01101 PMID: 38079601
  122. Tin Tin S, Smith-Byrne K, Ferrari P, Rinaldi S, McCullough ML, Teras LR, et al. (2024). Alcohol intake and endogenous sex hormones in women: Meta-analysis of cohort studies and Mendelian randomization. Cancer. 130(19): 3375-3386. https://doi.org/10.1002/cncr.35391 PMID: 38824654
  123. Tong TYN, Clarke R, Schmidt JA, Huybrechts I, Noor U, Forouhi NG, et al. (2024). Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries. Eur J Nutr. 63(1): 209-220. https://doi.org/10.1007/s00394-023-03251-4 PMID: 37804448
  124. Tsilidis KK, Markozannes G, Becerra-Tomas N, Cariolou M, Balducci K, Vieira R, et al. (2024). Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading. Int J Cancer. 155(3): 471-485. https://doi.org/10.1002/ijc.34904 PMID: 38692587
  125. Viallon V, Freisling H, Matta K, Nannsen AO, Dahm CC, Tjonneland A, et al. (2024). On the use of the healthy lifestyle index to investigate specific disease outcomes. Sci Rep. 14(1): 16330. https://doi.org/10.1038/s41598-024-66772-w PMID: 39009699
  126. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, et al. (2024). BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 89: 102545. https://doi.org/10.1016/j.canep.2024.102545 PMID: 38377945
  127. Wang SE, Viallon V, Lee M, Dimou N, Hamilton F, Biessy C, et al. (2024). Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses. EBioMedicine. 108: 105341. https://doi.org/10.1016/j.ebiom.2024.105341 PMID: 39278107
  128. Wesselink E, Gauderman W, Berndt SI, Brenner H, Buchanan DD, Campbell PT, et al. (2024). Calcium intake and genetic variants in the calcium sensing receptor in relation to colorectal cancer mortality: an international consortium study of 18,952 patients. BJC Rep. 2(1): 63. https://doi.org/10.1038/s44276-024-00077-3 PMID: 39233917
  129. Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, et al. (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 100: 104991. https://doi.org/10.1016/j.ebiom.2024.104991 PMID: 38301482
  130. Zheng JS, Steur M, Imamura F, Freisling H, Johnson L, van der Schouw YT, et al. (2024). Dietary intake of plant- and animal-derived protein and incident cardiovascular diseases: the pan-European EPIC-CVD case-cohort study. Am J Clin Nutr. 119(5): 1164-1174. https://doi.org/10.1016/j.ajcnut.2024.03.006 PMID: 38479550
  131. Aglago EK, Cross AJ, Riboli E, Fedirko V, Hughes DJ, Fournier A, et al. (2023). Dietary intake of total, heme and non-heme iron and the risk of colorectal cancer in a European prospective cohort study. Br J Cancer. 128(8): 1529-1540. https://doi.org/10.1038/s41416-023-02164-7 PMID: 36759722
  132. Aglago EK, Kim A, Lin Y, Qu C, Evangelou M, Ren Y, et al. (2023). A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk. Cancer Res. 83(15): 2572-2583. https://doi.org/10.1158/0008-5472.CAN-22-3713 PMID: 37249599
  133. Alcala K, Poustchi H, Viallon V, Islami F, Pourshams A, Sadjadi A, et al. (2023). Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. EClinicalMedicine. 64: 102229. https://doi.org/10.1016/j.eclinm.2023.102229 PMID: 37781157
  134. Alcolea JA, Donat-Vargas C, Chatziioannou AC, Keski-Rahkonen P, Robinot N, Molina AJ, et al. (2023). Metabolomic Signatures of Exposure to Nitrate and Trihalomethanes in Drinking Water and Colorectal Cancer Risk in a Spanish Multicentric Study (MCC-Spain). Environ Sci Technol. 57(48): 19316-19329. https://doi.org/10.1021/acs.est.3c05814 PMID: 37962559
  135. Alfano R, Zugna D, Barros H, Bustamante M, Chatzi L, Ghantous A, et al. (2023). Cord blood epigenome-wide meta-analysis in six European-based child cohorts identifies signatures linked to rapid weight growth. BMC Med. 21(1): 17. https://doi.org/10.1186/s12916-022-02685-7 PMID: 36627699
  136. Allione A, Viberti C, Cotellessa I, Catalano C, Casalone E, Cugliari G, et al. (2023). Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort. Int J Cancer. 152(4): 725-737. https://doi.org/10.1002/ijc.34339 PMID: 36305648
  137. Almanza-Aguilera E, Davila-Cordova E, Guinon-Fort D, Farras M, Masala G, Santucci de Magistris M, et al. (2023). Correlation Analysis between Dietary Intake of Tyrosols and Their Food Sources and Urinary Excretion of Tyrosol and Hydroxytyrosol in a European Population. Antioxidants (Basel). 12(3). https://doi.org/10.3390/antiox12030715 PMID: 36978963
  138. Aune D, Mahamat-Saleh Y, Kobeissi E, Feng T, Heath AK, Janszky I (2023). Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 38(2): 145-178. https://doi.org/10.1007/s10654-022-00914-0 PMID: 36626102
  139. Aune D, Schlesinger S, Mahamat-Saleh Y, Zheng B, Udeh-Momoh CT, Middleton LT (2023). Diabetes mellitus, prediabetes and the risk of Parkinson’s disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases. Eur J Epidemiol. 38(6): 591-604. https://doi.org/10.1007/s10654-023-00970-0 PMID: 37185794
  140. Ballout N, Etievant L, Viallon VJ (2023). On the use of cross-validation for the calibration of the adaptive lasso. Biom J. 65(5): e2200047. https://doi.org/10.1002/bimj.202200047 PMID: 36960476
  141. Becerra-Tomas N, Balducci K, Abar L, Aune D, Cariolou M, Greenwood DC, et al. (2023). Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. Int J Cancer. 152(4): 616-634. https://doi.org/10.1002/ijc.34321 PMID: 36279902
  142. Bennett M, Pistillo A, Recalde M, Reyes C, Freisling H, Duarte-Salles T (2023). Time trends in the incidence of cardiovascular disease, hypertension and diabetes by sex and socioeconomic status in Catalonia, Spain: a population-based cohort study. BMJ Open. 13(5): e066404. https://doi.org/10.1136/bmjopen-2022-066404 PMID: 37225269
  143. Blanco-Lopez J, Iguacel I, Pisanu S, Almeida CCB, Steliarova-Foucher E, Sierens C, et al. (2023). Role of Maternal Diet in the Risk of Childhood Acute Leukemia: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 20(7): 5428. https://doi.org/10.3390/ijerph20075428 PMID: 37048042
  144. Bolling BW, Aune D, Noh H, Petersen KS, Freisling H (2023). Dried Fruits, Nuts, and Cancer Risk and Survival: A Review of the Evidence and Future Research Directions. Nutrients. 15(6): 1443. https://doi.org/10.3390/nu15061443 PMID: 36986173
  145. Bonet C, Crous-Bou M, Tsilidis KK, Gunter MJ, Kaaks R, Schulze MB, et al. (2023). The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study. Eur J Epidemiol. 38(5): 545-557. https://doi.org/10.1007/s10654-023-00979-5 PMID: 36988840
  146. Botteri E, Peveri G, Berstad P, Bagnardi V, Chen SLF, Sandanger TM, et al. (2023). Changes in Lifestyle and Risk of Colorectal Cancer in the European Prospective Investigation Into Cancer and Nutrition. Am J Gastroenterol. 118(4): 702-711. https://doi.org/10.14309/ajg.0000000000002065 PMID: 36227801
  147. Bouras E, Kim AE, Lin Y, Morrison J, Du M, Albanes D, et al. (2023). Genome-wide interaction analysis of folate for colorectal cancer risk. Am J Clin Nutr. 118(5): 881-891. https://doi.org/10.1016/j.ajcnut.2023.08.010 PMID: 37640106
  148. Bull C, Hazelwood E, Bell JA, Tan V, Constantinescu AE, Borges C, et al. (2023). Identifying metabolic features of colorectal cancer liability using Mendelian randomization. Elife. 12: 26. https://doi.org/10.7554/eLife.87894 PMID: 38127078
  149. Cacau LT, Hanley-Cook GT, Huybrechts I, De Henauw S, Kersting M, Gonzalez-Gross M, et al. (2023). Relative validity of the Planetary Health Diet Index by comparison with usual nutrient intakes, plasma food consumption biomarkers, and adherence to the Mediterranean diet among European adolescents: the HELENA study. Eur J Nutr. 62(6): 2527-2539. https://doi.org/10.1007/s00394-023-03171-3 PMID: 37171585
  150. Cairat M, Pottegard A, Olesen M, Dossus L, Fournier A, Hicks B (2023). Antiplatelet drugs and breast cancer risk in a large nationwide Danish case-control study. Int J Cancer. 152(7): 1337-1347. https://doi.org/10.1002/ijc.34343 PMID: 36346115
  151. Cariolou M, Abar L, Aune D, Balducci K, Becerra-Tomas N, Greenwood DC, et al. (2023). Postdiagnosis recreational physical activity and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. Int J Cancer. 152(4): 600-615. https://doi.org/10.1002/ijc.34324 PMID: 36279903
  152. Carreras-Torres R, Kim AE, Lin Y, Diez-Obrero V, Bien SA, Qu C, et al. (2023). Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response. Cancer Epidemiol Biomarkers Prev. 32(3): 315-328. https://doi.org/10.1158/1055-9965.EPI-22-0763 PMID: 36576985
  153. Castaneda J, Gil-Lespinard M, Almanza-Aguilera E, Llaha F, Gomez JH, Bondonno N, et al. (2023). Association between classes and subclasses of polyphenol intake and 5-year body weight changes in the EPIC-PANACEA study. Obesity (Silver Spring). 31(4): 1146-1158. https://doi.org/10.1002/oby.23689 PMID: 36693804
  154. Castro-Espin C, Bonet C, Crous-Bou M, Katzke V, Le Cornet C, Jannasch F, et al. (2023). Dietary patterns related to biological mechanisms and survival after breast cancer diagnosis: results from a cohort study. Br J Cancer. 128(7): 1301-1310. https://doi.org/10.1038/s41416-023-02169-2 PMID: 36737658
  155. Castro-Espin C, Bonet C, Crous-Bou M, Nadal-Zaragoza N, Tjonneland A, Mellemkjaer L, et al. (2023). Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study. BMC Med. 21(1): 225. https://doi.org/10.1186/s12916-023-02934-3 PMID: 37365585
  156. Chaby LE, Lasseter HC, Contrepois K, Salek RM, Turck CW, Thompson A, et al. (2023). Correction: Chaby et al. Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites 2021, 11, 609. Metabolites. 13(8): 9. https://doi.org/10.3390/metabo13080933 PMID: 37623909
  157. Chan DSM, Vieira R, Abar L, Aune D, Balducci K, Cariolou M, et al. (2023). Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis. Int J Cancer. 152(4): 572-599. https://doi.org/10.1002/ijc.34322 PMID: 36279884
  158. Chang K, Gunter MJ, Rauber F, Levy RB, Huybrechts I, Kliemann N, et al. (2023). Ultra-processed food consumption, cancer risk and cancer mortality: a large-scale prospective analysis within the UK Biobank. EClinicalMedicine. 56: 101840. https://doi.org/10.1016/j.eclinm.2023.101840 PMID: 36880051
  159. Chapagain R, Giri B, Bhattarai T, Dhungana J, Walters M, Damasco E, et al. (2023). A cross-sectional study evaluating the prevalence and predictors of malnutrition among children and adolescents visiting an urban academic hospital in Nepal. Public Health Nutr. 26(12): 2738-2747. https://doi.org/10.1017/S136898002300188X PMID: 37811557
  160. Chen SLF, Nost TH, Botteri E, Ferrari P, Braaten T, Sandanger TM, et al. (2023). Overall lifestyle changes in adulthood are associated with cancer incidence in the Norwegian Women and Cancer Study (NOWAC) – a prospective cohort study. BMC Public Health. 23(1): 633. https://doi.org/10.1186/s12889-023-15476-3 PMID: 37013506
  161. Christakoudi S, Tsilidis KK, Dossus L, Rinaldi S, Weiderpass E, Antoniussen CS, et al. (2023). A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort. BMC Cancer. 23(1): 562. https://doi.org/10.1186/s12885-023-11056-1 PMID: 37337133
  162. Clasen JL, Mabunda R, Heath AK, Kaaks R, Katzke V, Schulze MB, et al. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14): 15588-15600. https://doi.org/10.1002/cam4.6207 PMID: 37269199
  163. Collaboration NCDRF (2023). Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. Nat Med. 29(11): 2885-2901. https://doi.org/10.1038/s41591-023-02610-2 PMID: 37946056
  164. Collaboration NCDRF (2023). Diminishing benefits of urban living for children and adolescents’ growth and development. Nature. 615(7954): 874-883. https://doi.org/10.1038/s41586-023-05772-8 PMID: 36991188
  165. Cross AJ, Gunter MJ (2023). Ultra-processed foods and colorectal neoplasia: is there a link? J Natl Cancer Inst. 115(2): 117-119. https://doi.org/10.1093/jnci/djac222 PMID: 36478262
  166. Davey Smith G, Hofman A, Brennan PD (2023). Chance, ignorance, and the paradoxes of cancer: Richard Peto on developing preventative strategies under uncertainty. Eur J Epidemiol. 38(12): 1227-1237. https://doi.org/10.1007/s10654-023-01090-5 PMID: 38147198
  167. Debras C, Deschasaux-Tanguy M, Chazelas E, Sellem L, Druesne-Pecollo N, Esseddik Y, et al. (2023). Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Sante Cohort. Diabetes Care. 46(9): 1681-1690. https://doi.org/10.2337/dc23-0206 PMID: 37490630
  168. Dimou N, Kim AE, Flanagan O, Murphy N, Diez-Obrero V, Shcherbina A, et al. (2023). Probing the diabetes and colorectal cancer relationship using gene – environment interaction analyses. Br J Cancer. 129(3): 511-520. https://doi.org/10.1038/s41416-023-02312-z PMID: 37365285
  169. Ersoy Guller Z, Harewood RN, Weiderpass E, Huybrechts I, Jenab M, Huerta JM, et al. (2023). Diet and lifestyle in relation to small intestinal cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control. 34(10): 927-937. https://doi.org/10.1007/s10552-023-01731-w PMID: 37330982
  170. Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al. (2023). Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat Genet. 55(1): 89-99. https://doi.org/10.1038/s41588-022-01222-9 PMID: 36539618
  171. Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, et al. (2023). Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat Genet. 55(3): 519-520. https://doi.org/10.1038/s41588-023-01334-w PMID: 36782065
  172. Flieh SM, Miguel-Berges ML, Huybrechts I, Breidenassel C, Grammatikaki E, Donne CL, et al. (2023). Food portion sizes and their relationship with energy, and nutrient intakes in adolescents: The HELENA study. Nutrition. 106: 111893. https://doi.org/10.1016/j.nut.2022.111893 PMID: 36462317
  173. Fontvieille E, Viallon V, Recalde M, Cordova R, Jansana A, Peruchet-Noray L, et al. (2023). Body mass index and cancer risk among adults with and without cardiometabolic diseases: evidence from the EPIC and UK Biobank prospective cohort studies. BMC Med. 21(1): 418. https://doi.org/10.1186/s12916-023-03114-z PMID: 37993940
  174. Fournier A, Cairat M, Severi G, Gunter MJ, Rinaldi S, Dossus L (2023). Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study. J Natl Cancer Inst. 115(6): 671-679. https://doi.org/10.1093/jnci/djad035 PMID: 36809347
  175. Glenn AJ, Aune D, Freisling H, Mohammadifard N, Kendall CWC, Salas-Salvado J, et al. (2023). Nuts and Cardiovascular Disease Outcomes: A Review of the Evidence and Future Directions. Nutrients. 15(4): 911. https://doi.org/10.3390/nu15040911 PMID: 36839269
  176. Hanley-Cook GT, Daly AJ, Remans R, Jones AD, Murray KA, Huybrechts I, et al. (2023). Food biodiversity: Quantifying the unquantifiable in human diets. Crit Rev Food Sci Nutr. 63(25): 7837-7851. https://doi.org/10.1080/10408398.2022.2051163 PMID: 35297716
  177. Harbs J, Rinaldi S, Keski-Rahkonen P, Liu X, Palmqvist R, Van Guelpen B, et al. (2023). An epigenome-wide analysis of sex hormone levels and DNA methylation in male blood samples. Epigenetics. 18(1): 2196759. https://doi.org/10.1080/15592294.2023.2196759 PMID: 36994855
  178. Hatcher C, Richenberg G, Waterson S, Nguyen LH, Joshi AD, Carreras-Torres R, et al. (2023). Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer. Sci Rep. 13(1): 5968. https://doi.org/10.1038/s41598-023-31840-0 PMID: 37045850
  179. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Burgess S, Khankari NK, et al. (2023). The association between genetically elevated polyunsaturated fatty acids and risk of cancer. EBioMedicine. 91: 104510. https://doi.org/10.1016/j.ebiom.2023.104510 PMID: 37086649
  180. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Harrison S, Burgess S, et al. (2023). Design and quality control of large-scale two-sample Mendelian randomization studies. Int J Epidemiol. 52(5): 1498-1521. https://doi.org/10.1093/ije/dyad018 PMID: 38587501
  181. Hughes DJ, Schomburg L, Jenab M, Biessy C, Meplan C, Moskal A, et al. (2023). Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a European cohort study. Free Radic Biol Med. 209(Pt 2): 381-393. https://doi.org/10.1016/j.freeradbiomed.2023.10.401 PMID: 37923090
  182. Huybrechts I, Jacobs I, Aglago EK, Yammine S, Matta M, Schmidt JA, et al. (2023). Associations between Fatty Acid Intakes and Plasma Phospholipid Fatty Acid Concentrations in the European Prospective Investigation into Cancer and Nutrition. Nutrients. 15(17). https://doi.org/10.3390/nu15173695 PMID: 37686727
  183. Huybrechts I, Rauber F, Nicolas G, Casagrande C, Kliemann N, Wedekind R, et al. (2023). Corrigendum: Characterization of the degree of food processing in the European Prospective Investigation into Cancer and Nutrition: application of the Nova classification and validation using selected biomarkers of food processing. Front Nutr. 10: 1207555. https://doi.org/10.3389/fnut.2023.1207555 PMID: 37260516
  184. Karavasiloglou N, Hughes DJ, Murphy N, Schomburg L, Sun Q, Seher V, et al. (2023). Prediagnostic serum calcium concentrations and risk of colorectal cancer development in 2 large European prospective cohorts. Am J Clin Nutr. 117(1): 33-45. https://doi.org/10.1016/j.ajcnut.2022.10.004 PMID: 36789942
  185. Kenkhuis MF, Klingestijn M, Fanshawe AM, Breukink SO, Janssen-Heijnen MLG, Keulen ETP, et al. (2023). Longitudinal associations of sedentary behavior and physical activity with body composition in colorectal cancer survivors up to 2 years post treatment. J Cancer Res Clin Oncol. 149(7): 4063-4075. https://doi.org/10.1007/s00432-022-04267-9 PMID: 36040665
  186. King SD, Veliginti S, Brouwers M, Ren Z, Zheng W, Setiawan VW, et al. (2023). Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiol Biomarkers Prev. 32(9): 1265-1269. https://doi.org/10.1158/1055-9965.EPI-23-0453 PMID: 37351909
  187. Kintossou AK, Blanco-Lopez J, Iguacel I, Pisanu S, Almeida CCB, Steliarova-Foucher E, et al. (2023). Early Life Nutrition Factors and Risk of Acute Leukemia in Children: Systematic Review and Meta-Analysis. Nutrients. 15(17): 15. https://doi.org/10.3390/nu15173775 PMID: 37686807
  188. Kliemann N, Rauber F, Bertazzi Levy R, Viallon V, Vamos EP, Cordova R, et al. (2023). Food processing and cancer risk in Europe: results from the prospective EPIC cohort study. Lancet Planet Health. 7(3): e219-e232. https://doi.org/10.1016/S2542-5196(23)00021-9 PMID: 36889863
  189. Knaze V, Freisling H, Cook P, Heise K, Acevedo J, Cikutovic M, et al. (2023). Association between salt intake and gastric atrophy by Helicobacter pylori infection: first results from the Epidemiological Investigation of Gastric Malignancy (ENIGMA). Eur J Nutr. 62(5): 2129-2138. https://doi.org/10.1007/s00394-023-03132-w PMID: 36964250
  190. Koistinen V, Karkkainen O, Keski-Rahkonen P, Tsugawa H, Scalbert A, Arita M, et al. (2023). Towards a Rosetta stone for metabolomics: recommendations to overcome inconsistent metabolite nomenclature. Nat Metab. 5(3): 351-354. https://doi.org/10.1038/s42255-023-00757-3 PMID: 36890347
  191. Laanani M, Viallon V, Coste J, Rey G (2023). Collider and reporting biases involved in the analyses of cause of death associations in death certificates: an illustration with cancer and suicide. Popul Health Metr. 21(1): 21. https://doi.org/10.1186/s12963-023-00320-y PMID: 38098030
  192. Lecuyer L, Laouali N, Viallon V, Artaud F, Hebert JR, Shivappa N, et al. (2023). Associations between dietary inflammatory scores and biomarkers of inflammation in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Clin Nutr. 42(7): 1115-1125. https://doi.org/10.1016/j.clnu.2023.05.012 PMID: 37271707
  193. Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, et al. (2023). Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. J Med Genet. 60(12): 1186-1197. https://doi.org/10.1136/jmg-2023-109185 PMID: 37451831
  194. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. https://doi.org/10.1136/gutjnl-2022-328233 PMID: 36241389
  195. Lindstrom S, Wang L, Feng H, Majumdar A, Huo S, Macdonald J, et al. (2023). Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 115(6): 712-732. https://doi.org/10.1093/jnci/djad043 PMID: 36929942
  196. Loding S, Andersson U, Kaaks R, Schulze MB, Pala V, Urbarova I, et al. (2023). Altered plasma metabolite levels can be detected years before a glioma diagnosis. JCI Insight. 8(19): e171225. https://doi.org/10.1172/jci.insight.171225 PMID: 37651185
  197. Macciotta A, Catalano A, Giraudo MT, Weiderpass E, Ferrari P, Freisling H, et al. (2023). Mediating Role of Lifestyle Behaviors in the Association between Education and Cancer: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 32(1): 132-140. https://doi.org/10.1158/1055-9965.EPI-22-0777 PMID: 36306379
  198. Mahamat-Saleh Y, Al-Rahmoun M, Severi G, Ghiasvand R, Veierod MB, Caini S, et al. (2023). Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). Int J Cancer. 152(3): 348-362. https://doi.org/10.1002/ijc.34253 PMID: 36053839
  199. Mahamat-Saleh Y, Rinaldi S, Kaaks R, Biessy C, Gonzalez-Gil EM, Murphy N, et al. (2023). Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(11): 12668-12682. https://doi.org/10.1002/cam4.5896 PMID: 37096432
  200. Mao Z, Baker JR, Takeuchi M, Hyogo H, Tjonneland A, Eriksen AK, et al. (2023). Prediagnostic serum glyceraldehyde-derived advanced glycation end products and mortality among colorectal cancer patients. Int J Cancer. 152(11): 2257-2268. https://doi.org/10.1002/ijc.34449 PMID: 36715363
  201. Martinez-Steele E, Khandpur N, Batis C, Bes-Rastrollo M, Bonaccio M, Cediel G, et al. (2023). Best practices for applying the Nova food classification system. Nat Food. 4(6): 445-448. https://doi.org/10.1038/s43016-023-00779-w PMID: 37264165
  202. Meyer A, Dong C, Casagrande C, Chan SSM, Huybrechts I, Nicolas G, et al. (2023). Food Processing and Risk of Crohn’s Disease and Ulcerative Colitis: A European Prospective Cohort Study. Clin Gastroenterol Hepatol. 21(6): 1607-1616 e1606. https://doi.org/10.1016/j.cgh.2022.09.031 PMID: 36243353
  203. Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, et al. (2023). A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Res. 25(1): 93. https://doi.org/10.1186/s13058-023-01691-8 PMID: 37559094
  204. Moradell A, Santaliestra-Pasias AM, Aparicio-Ugarriza R, Huybrechts I, Bertalanne Szommer A, Forsner M, et al. (2023). Are Physical Activity and Sedentary Screen Time Levels Associated With Food Consumption in European Adolescents? The HELENA Study. J Am Nutr Assoc. 42(1): 55-66. https://doi.org/10.1080/07315724.2021.1978900 PMID: 35512776
  205. Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, et al. (2023). Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Med. 15(1): 7. https://doi.org/10.1186/s13073-022-01152-5 PMID: 36703164
  206. Murphy N, Newton CC, Song M, Papadimitriou N, Hoffmeister M, Phipps AI, et al. (2023). Body mass index and molecular subtypes of colorectal cancer. J Natl Cancer Inst. 115(2): 165-173. https://doi.org/10.1093/jnci/djac215 PMID: 36445035
  207. Neveu V, Nicolas G, Amara A, Salek RM, Scalbert A (2023). The human microbial exposome: expanding the Exposome-Explorer database with gut microbial metabolites. Sci Rep. 13(1): 1946. https://doi.org/10.1038/s41598-022-26366-w PMID: 36732606
  208. Nimptsch K, Aleksandrova K, Pham TT, Papadimitriou N, Janke J, Christakoudi S, et al. (2023). Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer. BMC Med. 21(1): 391. https://doi.org/10.1186/s12916-023-03104-1 PMID: 37833736
  209. Oosterwegel MJ, Ibi D, Portengen L, Probst-Hensch N, Tarallo S, Naccarati A, et al. (2023). Variability of the Human Serum Metabolome over 3 Months in the EXPOsOMICS Personal Exposure Monitoring Study. Environ Sci Technol. 57(34): 12752-12759. https://doi.org/10.1021/acs.est.3c03233 PMID: 37582220
  210. Orfanidis A, Gika H, Theodoridis G, Chatziioannou AC, Raikos N (2023). Analysis, Stability and Distribution of Pharmaceuticals and Drugs of Abuse over a Period of One Year in Formalin-Fixed Liver and Formalin Solutions. J Anal Toxicol. 47(2): 182-190. https://doi.org/10.1093/jat/bkac060 PMID: 35957494
  211. Ose J, Gigic B, Brezina S, Lin T, Peoples AR, Schobert PP, et al. (2023). Higher Plasma Creatinine Is Associated with an Increased Risk of Death in Patients with Non-Metastatic Rectal but Not Colon Cancer: Results from an International Cohort Consortium. Cancers (Basel). 15(13): 15. https://doi.org/10.3390/cancers15133391 PMID: 37444500
  212. Papadimitriou N, Bull CJ, Jenab M, Hughes DJ, Bell JA, Sanderson E, et al. (2023). Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. BMC Med. 21(1): 5. https://doi.org/10.1186/s12916-022-02702-9 PMID: 36600297
  213. Papadimitriou N, Kazmi N, Dimou N, Tsilidis KK, Martin RM, Lewis SJ, et al. (2023). Leisure time television watching, computer use and risks of breast, colorectal and prostate cancer: A Mendelian randomisation analysis. Cancer Med. 13(1): 18. https://doi.org/10.1002/cam4.6732 PMID: 38155458
  214. Parmenter BH, Dalgaard F, Murray K, Marquis-Gravel G, Cassidy A, Bondonno CP, et al. (2023). Intake of dietary flavonoids and incidence of ischemic heart disease in the Danish Diet, Cancer, and Health cohort. Eur J Clin Nutr. 77(2): 270-277. https://doi.org/10.1038/s41430-022-01226-y PMID: 36284213
  215. Pasqual E, O’Brien K, Rinaldi S, Sandler DP, Kitahara CM (2023). Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study). Lancet Reg Health Am. 23: 100537. https://doi.org/10.1016/j.lana.2023.100537 PMID: 37346380
  216. Perperidi M, Saliari D, Christakis C, Huybrechts I, Saloustros E, Theodorakis Y, et al. (2023). Identifying the effective behaviour change techniques in nutrition and physical activity interventions for the treatment of overweight/obesity in post-treatment breast cancer survivors: a systematic review. Cancer Causes Control. 34(8): 683-703. https://doi.org/10.1007/s10552-023-01707-w PMID: 37149509
  217. Peruchet-Noray L, Dimou N, Sedlmeier AM, Fervers B, Romieu I, Viallon V, et al. (2023). Body Shape Phenotypes and Breast Cancer Risk: A Mendelian Randomization Analysis. Cancers (Basel). 15(4). https://doi.org/10.3390/cancers15041296 PMID: 36831637
  218. Peterson L, Lee H, Huybrechts I, Biessy C, Neuhouser ML, Haaland B, et al. (2023). Reliability estimates for assessing meal timing derived from longitudinal repeated 24-hour dietary recalls. Am J Clin Nutr. 117(5): 964-975. https://doi.org/10.1016/j.ajcnut.2023.02.026 PMID: 36921904
  219. Pham TT, Nimptsch K, Papadimitriou N, Aleksandrova K, Jenab M, Gunter MJ, et al. (2023). Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study. J Cancer Res Clin Oncol. 149(16): 14889-14900. https://doi.org/10.1007/s00432-023-05193-0 PMID: 37599317
  220. Recalde M, Pistillo A, Davila-Batista V, Leitzmann M, Romieu I, Viallon V, et al. (2023). Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults. Nat Commun. 14(1): 3816. https://doi.org/10.1038/s41467-023-39282-y PMID: 37391446
  221. Recalde M, Pistillo A, Viallon V, Fontvieille E, Duarte-Salles T, Freisling H (2023). Body mass index and incident cardiometabolic conditions in relation to obesity-related cancer risk: A population-based cohort study in Catalonia, Spain. Cancer Med. 12(19): 20188-20200. https://doi.org/10.1002/cam4.6603 PMID: 37766588
  222. Rogers M, Gill D, Ahlqvist E, Robinson T, Mariosa D, Johansson M, et al. (2023). Genetically proxied impaired GIPR signaling and risk of 6 cancers. iScience. 26(6): 106848. https://doi.org/10.1016/j.isci.2023.106848 PMID: 37250804
  223. Rothwell JA, Besevic J, Dimou N, Breeur M, Murphy N, Jenab M, et al. (2023). Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts. BMC Med. 21(1): 80. https://doi.org/10.1186/s12916-023-02739-4 PMID: 36855092
  224. Sanikini H, Biessy C, Rinaldi S, Navionis AS, Gicquiau A, Keski-Rahkonen P, et al. (2023). Circulating hormones and risk of gastric cancer by subsite in three cohort studies. Gastric Cancer. 26(6): 969-987. https://doi.org/10.1007/s10120-023-01414-0 PMID: 37455285
  225. Schmidt JA, Huybrechts I, Overvad K, Eriksen AK, Tjonneland A, Kaaks R, et al. (2023). Protein and amino acid intakes in relation to prostate cancer risk and mortality-A prospective study in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(4): 4725-4738. https://doi.org/10.1002/cam4.5289 PMID: 36148781
  226. Sedlmeier AM, Viallon V, Ferrari P, Peruchet-Noray L, Fontvieille E, Amadou A, et al. (2023). Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study. Br J Cancer. 128(4): 594-605. https://doi.org/10.1038/s41416-022-02071-3 PMID: 36460776
  227. Sellem L, Srour B, Javaux G, Chazelas E, Chassaing B, Viennois E, et al. (2023). Food additive emulsifiers and risk of cardiovascular disease in the NutriNet-Sante cohort: prospective cohort study. BMJ. 382: e076058. https://doi.org/10.1136/bmj-2023-076058 PMID: 37673430
  228. Seral-Cortes M, Sabroso-Lasa S, Gonzalez-Gross M, Quesada-Gonzalez C, Stehle P, Gottrand F, et al. (2023). The body mass index increases the genetic risk scores’ ability to predict risk of hepatic damage in European adolescents: The HELENA study. Eur J Clin Invest. 53(12): e14081. https://doi.org/10.1111/eci.14081 PMID: 37608495
  229. Shah S, Mahamat-Saleh Y, Ait-Hadad W, Koemel NA, Varraso R, Boutron-Ruault MC, et al. (2023). Long-term adherence to healthful and unhealthful plant-based diets and breast cancer risk overall and by hormone receptor and histologic subtypes among postmenopausal females. Am J Clin Nutr. 117(3): 467-476. https://doi.org/10.1016/j.ajcnut.2022.11.019 PMID: 36872016
  230. Shah SA, Mahamat-Saleh Y, Hajji-Louati M, Correia E, Oulhote Y, Boutron-Ruault MC, et al. (2023). Palaeolithic diet score and risk of breast cancer among postmenopausal women overall and by hormone receptor and histologic subtypes. Eur J Clin Nutr. 77(5): 596-602. https://doi.org/10.1038/s41430-023-01267-x PMID: 36726032
  231. Srour B, Chazelas E, Druesne-Pecollo N, Esseddik Y, de Edelenyi FS, Agaesse C, et al. (2023). Dietary exposure to nitrites and nitrates in association with type 2 diabetes risk: Results from the NutriNet-Sante population-based cohort study. PLoS Med. 20(1): e1004149. https://doi.org/10.1371/journal.pmed.1004149 PMID: 36649248
  232. Stein MJ, Baurecht H, Sedlmeier AM, Konzok J, Bohmann P, Fontvieille E, et al. (2023). Association between circadian physical activity patterns and mortality in the UK Biobank. International Journal of Behavioral Nutrition and Physical Activity. 20(1): 102. https://doi.org/10.1186/s12966-023-01508-z PMID: 37653438
  233. Su YR, Sakoda LC, Jeon J, Thomas M, Lin Y, Schneider JL, et al. (2023). Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort. Cancer Epidemiol Biomarkers Prev. 32(3): 353-362. https://doi.org/10.1158/1055-9965.EPI-22-0817 PMID: 36622766
  234. Thomas M, Su YR, Rosenthal EA, Sakoda LC, Schmit SL, Timofeeva MN, et al. (2023). Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations. Nat Commun. 14(1): 6147. https://doi.org/10.1038/s41467-023-41819-0 PMID: 37783704
  235. Thompson AS, Tresserra-Rimbau A, Karavasiloglou N, Jennings A, Cantwell M, Hill C, et al. (2023). Association of Healthful Plant-based Diet Adherence With Risk of Mortality and Major Chronic Diseases Among Adults in the UK. JAMA Netw Open. 6(3): e234714. https://doi.org/10.1001/jamanetworkopen.2023.4714 PMID: 36976560
  236. Tsilidis KK, Cariolou M, Becerra-Tomas N, Balducci K, Vieira R, Abar L, et al. (2023). Postdiagnosis body fatness, recreational physical activity, dietary factors and breast cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading. Int J Cancer. 152(4): 635-644. https://doi.org/10.1002/ijc.34320 PMID: 36279885
  237. Ugai T, Akimoto N, Haruki K, Harrison TA, Cao Y, Qu C, et al. (2023). Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases. J Gastroenterol. 58(3): 229-245. https://doi.org/10.1007/s00535-023-01955-2 PMID: 36648535
  238. Ugai T, Haruki K, Harrison TA, Cao Y, Qu C, Chan AT, et al. (2023). Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases. Am J Gastroenterol. 118(4): 712-726. https://doi.org/10.14309/ajg.0000000000002171 PMID: 36707929
  239. Van Puyvelde H, Dimou N, Katsikari A, Indave Ruiz BI, Godderis L, Huybrechts I, et al. (2023). The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. Cancer Epidemiol. 83: 102322. https://doi.org/10.1016/j.canep.2023.102322 PMID: 36701983
  240. van Roekel EH, Bours MJL, Breukink SO, Aquarius M, Keulen ETP, Gicquiau A, et al. (2023). Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment. Int J Cancer. 152(2): 214-226. https://doi.org/10.1002/ijc.34252 PMID: 36054767
  241. Vidman L, Zheng R, Bodén S, Ribbenstedt A, Gunter MJ, Palmqvist R, et al. (2023). Untargeted plasma metabolomics and risk of colorectal cancer-an analysis nested within a large-scale prospective cohort. Cancer Metab. 11(1): 17. https://doi.org/10.1186/s40170-023-00319-x PMID: 37849011
  242. Visvanathan K, Mondul AM, Zeleniuch-Jacquotte A, Wang M, Gail MH, Yaun SS, et al. (2023). Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. Eur J Epidemiol. 38(1): 11-29. https://doi.org/10.1007/s10654-022-00921-1 PMID: 36593337
  243. Watling CZ, Kelly RK, Murphy N, Gunter M, Piernas C, Bradbury KE, et al. (2023). Prospective Analysis Reveals Associations between Carbohydrate Intakes, Genetic Predictors of Short-Chain Fatty Acid Synthesis, and Colorectal Cancer Risk. Cancer Res. 83(12): 2066-2076. https://doi.org/10.1158/0008-5472.CAN-22-3755 PMID: 37097623
  244. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2023). Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis. Int J Epidemiol. 52(1): 71-86. https://doi.org/10.1093/ije/dyac124 PMID: 35726641
  245. Wendeu-Foyet G, Bellicha A, Chajes V, Huybrechts I, Bard JM, Debras C, et al. (2023). Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Sante Prospective Cohort. Diabetes Care. 46(2): 321-330. https://doi.org/10.2337/dc22-0900 PMID: 36542554
  246. Winn M, Karra P, Freisling H, Gunter MJ, Haaland B, Litchman ML, et al. (2023). Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination Survey. Endocrinol Diabetes Metab. 6(4): e433. https://doi.org/10.1002/edm2.433 PMID: 37277888
  247. Winn M, Karra P, Haaland B, Doherty JA, Summers SA, Litchman ML, et al. (2023). Metabolic dysfunction and obesity-related cancer: Results from the cross-sectional National Health and Nutrition Examination Survey. Cancer Med. 12(1): 606-618. https://doi.org/10.1002/cam4.4912 PMID: 35719035
  248. Yammine SG, Huybrechts I, Biessy C, Dossus L, Panico S, Sanchez MJ, et al. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1): 159. https://doi.org/10.1186/s12885-023-10611-0 PMID: 36797668
  249. Yarmolinsky J, Bouras E, Constantinescu A, Burrows K, Bull CJ, Vincent EE, et al. (2023). Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia. 66(8): 1481-1500. https://doi.org/10.1007/s00125-023-05925-4 PMID: 37171501
  250. Zamora-Ros R, Cayssials V, Cleries R, Torrents M, Byrnes G, Weiderpass E, et al. (2023). Sweetened beverages are associated with a higher risk of differentiated thyroid cancer in the EPIC cohort: a dietary pattern approach. Eur J Nutr. 62(1): 105-114. https://doi.org/10.1007/s00394-022-02953-5 PMID: 35907037
  251. Zhang T, Naudin S, Hong HG, Albanes D, Mannisto S, Weinstein SJ, et al. (2023). Dietary Quality and Circulating Lipidomic Profiles in 2 Cohorts of Middle-Aged and Older Male Finnish Smokers and American Populations. J Nutr. 153(8): 2389-2400. https://doi.org/10.1016/j.tjnut.2023.06.010 PMID: 37328109
  252. Zhao Y, Walker DI, Lill CM, Bloem BR, Darweesh SKL, Pinto-Pacheco B, et al. (2023). Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort. J Neuroinflammation. 20(1): 170. https://doi.org/10.1186/s12974-023-02846-2 PMID: 37480114
  253. Al Rahmoun M, Ghiasvand R, Cairat M, Mahamat-Saleh Y, Cervenka I, Severi G, et al. (2022). Statin Use and Skin Cancer Risk: A Prospective Cohort Study. J Invest Dermatol. 142(5): 1318-1325 e1315. https://doi.org/10.1016/j.jid.2021.10.010 PMID: 34695411
  254. Alfano R, Plusquin M, Robinson O, Brescianini S, Chatzi L, Keski-Rahkonen P, et al. (2022). Cord blood metabolites and rapid postnatal growth as multiple mediators in the prenatal propensity to childhood overweight. Int J Obes (Lond). 46(7): 1384-1393. https://doi.org/10.1038/s41366-022-01108-0 PMID: 35508813
  255. Amara A, Frainay C, Jourdan F, Naake T, Neumann S, Novoa-Del-Toro EM, et al. (2022). Networks and Graphs Discovery in Metabolomics Data Analysis and Interpretation. Front Mol Biosci. 9: 841373. https://doi.org/10.3389/fmolb.2022.841373 PMID: 35350714
  256. Archambault AN, Jeon J, Lin Y, Thomas M, Harrison TA, Bishop DT, et al. (2022). Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study. J Natl Cancer Inst. 114(4): 528-539. https://doi.org/10.1093/jnci/djac003 PMID: 35026030
  257. Aune D, Markozannes G, Abar L, Balducci K, Cariolou M, Nanu N, et al. (2022). Physical Activity and Health-Related Quality of Life in Women With Breast Cancer: A Meta-Analysis. JNCI Cancer Spectr. 6(6). https://doi.org/10.1093/jncics/pkac072 PMID: 36474321
  258. Barfield R, Huyghe JR, Lemire M, Dong X, Su YR, Brezina S, et al. (2022). Genetic Regulation of DNA Methylation Yields Novel Discoveries in GWAS of Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 31(5): 1068-1076. https://doi.org/10.1158/1055-9965.EPI-21-0724 PMID: 35247911
  259. Bellerba F, Chatziioannou AC, Jasbi P, Robinot N, Keski-Rahkonen P, Trolat A, et al. (2022). Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials. J Transl Med. 20(1): 629. https://doi.org/10.1186/s12967-022-03809-6 PMID: 36581893
  260. Bond TA, Richmond RC, Karhunen V, Cuellar-Partida G, Borges MC, Zuber V, et al. (2022). Exploring the causal effect of maternal pregnancy adiposity on offspring adiposity: Mendelian randomisation using polygenic risk scores. BMC Med. 20(1): 34. https://doi.org/10.1186/s12916-021-02216-w PMID: 35101027
  261. Bondonno NP, Parmenter BH, Dalgaard F, Murray K, Rasmussen DB, Kyro C, et al. (2022). Flavonoid intakes inversely associate with COPD in smokers. Eur Respir J. 60(2): 2102604. https://doi.org/10.1183/13993003.02604-2021 PMID: 35058251
  262. Boot IWA, Wesselius A, Yu EYW, Brinkman M, van den Brandt P, Grant EJ, et al. (2022). Dietary B group vitamin intake and the bladder cancer risk: a pooled analysis of prospective cohort studies. Eur J Nutr. 61(5): 2397-2416. https://doi.org/10.1007/s00394-022-02805-2 PMID: 35129646
  263. Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, et al. (2022). Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 20(1): 3. https://doi.org/10.1186/s12916-021-02193-0 PMID: 35012533
  264. Bray F, Parkin DM, African Cancer Registry N (2022). Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncol. 23(6): 719-728. https://doi.org/10.1016/S1470-2045(22)00270-4 PMID: 35550275
  265. Breeur M, Ferrari P, Dossus L, Jenab M, Johansson M, Rinaldi S, et al. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20(1): 351. https://doi.org/10.1186/s12916-022-02553-4 PMID: 36258205
  266. Cairat M, Rinaldi S, Navionis AS, Romieu I, Biessy C, Viallon V, et al. (2022). Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort. BMC Med. 20(1): 118. https://doi.org/10.1186/s12916-022-02319-y PMID: 35430795
  267. Campbell PT, Newton CC, Jacobs EJ, McCullough ML, Wang Y, Rees-Punia E, et al. (2022). Prospective associations of hemoglobin A(1c) and c-peptide with risk of diabetes-related cancers in the Cancer Prevention Study-II Nutrition Cohort. Cancer Res Commun. 2(7): 653-662. https://doi.org/10.1158/2767-9764.crc-22-0082 PMID: 36712480
  268. Cayssials V, Buckland G, Crous-Bou M, Bonet C, Weiderpass E, Skie G, et al. (2022). Inflammatory potential of diet and pancreatic cancer risk in the EPIC study. Eur J Nutr. 61(5): 2313-2320. https://doi.org/10.1007/s00394-022-02809-y PMID: 35091827
  269. Chan SSM, Chen Y, Casey K, Olen O, Ludvigsson JF, Carbonnel F, et al. (2022). Obesity is Associated With Increased Risk of Crohn’s disease, but not Ulcerative Colitis: A Pooled Analysis of Five Prospective Cohort Studies. Clin Gastroenterol Hepatol. 20(5): 1048-1058. https://doi.org/10.1016/j.cgh.2021.06.049 PMID: 34242756
  270. Charvat H, Freisling H, Noh H, Gaudet MM, Gunter MJ, Cross AJ, et al. (2022). Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies. Cancer Epidemiol Biomarkers Prev. 31(2): 325-333. https://doi.org/10.1158/1055-9965.EPI-21-0688 PMID: 34782393
  271. Chazelas E, Pierre F, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaesse C, et al. (2022). Nitrites and nitrates from food additives and natural sources and cancer risk: results from the NutriNet-Sante cohort. Int J Epidemiol. 51(4): 1106-1119. https://doi.org/10.1093/ije/dyac046 PMID: 35303088
  272. Claeys L, De Saeger S, Scelo G, Biessy C, Casagrande C, Nicolas G, et al. (2022). Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort. Nutrients. 14(17): 3581. https://doi.org/10.3390/nu14173581 PMID: 36079840
  273. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer. 151(5): 708-716. https://doi.org/10.1002/ijc.34009 PMID: 35366005
  274. Cordova R, Mayen AL, Knaze V, Aglago EK, Schalkwijk C, Wagner KH, et al. (2022). Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study. Cancer Commun (Lond). 42(10): 1041-1045. https://doi.org/10.1002/cac2.12343 PMID: 35924960
  275. Crous-Bou M, Du M, Gunter MJ, Setiawan VW, Schouten LJ, Shu XO, et al. (2022). Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2). Am J Clin Nutr. 116(5): 1219-1228. https://doi.org/10.1093/ajcn/nqac229 PMID: 36041172
  276. Dam V, Onland-Moret NC, Burgess S, Chirlaque MD, Peters SAE, Schuit E, et al. (2022). Genetically Determined Reproductive Aging and Coronary Heart Disease: A Bidirectional 2-sample Mendelian Randomization. J Clin Endocrinol Metab. 107(7): e2952-e2961. https://doi.org/10.1210/clinem/dgac171 PMID: 35306566
  277. Dashti SG, Simpson JA, Viallon V, Karahalios A, Moreno-Betancur M, Brasky T, et al. (2022). Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Med. 11(4): 1145-1159. https://doi.org/10.1002/cam4.4434 PMID: 35048536
  278. de Barros BV, Proenca R, Kliemann N, Hilleshein D, de Souza AA, Cembranel F, et al. (2022). Trans-Fat Labeling in Packaged Foods Sold in Brazil Before and After Changes in Regulatory Criteria for Trans-Fat-Free Claims on Food Labels. Front Nutr. 9: 868341. https://doi.org/10.3389/fnut.2022.868341 PMID: 35662949
  279. Debras C, Chazelas E, Sellem L, Porcher R, Druesne-Pecollo N, Esseddik Y, et al. (2022). Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Sante cohort. BMJ. 378: e071204. https://doi.org/10.1136/bmj-2022-071204 PMID: 36638072
  280. Debras C, Chazelas E, Srour B, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, et al. (2022). Artificial sweeteners and cancer risk: Results from the NutriNet-Sante population-based cohort study. PLoS Med. 19(3): e1003950. https://doi.org/10.1371/journal.pmed.1003950 PMID: 35324894
  281. Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, et al. (2022). Rare germline copy number variants (CNVs) and breast cancer risk. Commun Biol. 5(1): 65. https://doi.org/10.1038/s42003-021-02990-6 PMID: 35042965
  282. DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, et al. (2022). Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. J Natl Cancer Inst. 114(11): 1533-1544. https://doi.org/10.1093/jnci/djac160 PMID: 36210504
  283. Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, et al. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. Int J Cancer. 151(1): 44-55. https://doi.org/10.1002/ijc.33970 PMID: 35182086
  284. Dimou N, Omiyale W, Biessy C, Viallon V, Kaaks R, O’Mara TA, et al. (2022). Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 31(9): 1839-1848. https://doi.org/10.1158/1055-9965.EPI-21-1176 PMID: 35900194
  285. Dong C, Chan SSM, Jantchou P, Racine A, Oldenburg B, Weiderpass E, et al. (2022). Meat Intake Is Associated with a Higher Risk of Ulcerative Colitis in a Large European Prospective Cohort Studyo. J Crohns Colitis. 16(8): 1187-1196. https://doi.org/10.1093/ecco-jcc/jjac054 PMID: 35396592
  286. Dugue PA, Hodge AM, Ulvik A, Ueland PM, Midttun O, Rinaldi S, et al. (2022). Association of Markers of Inflammation, the Kynurenine Pathway and B Vitamins with Age and Mortality, and a Signature of Inflammaging. J Gerontol A Biol Sci Med Sci. 77(4): 826-836. https://doi.org/10.1093/gerona/glab163 PMID: 34117761
  287. El Asri A, Ouldim K, Bouguenouch L, Sekal M, Moufid FZ, Kampman E, et al. (2022). Dietary Fat Intake and KRAS Mutations in Colorectal Cancer in a Moroccan Population. Nutrients. 14(2): 12. https://doi.org/10.3390/nu14020318 PMID: 35057499
  288. El Kinany K, Huybrechts I, Hatime Z, El Asri A, Boudouaya HA, Deoula MMS, et al. (2022). Food processing groups and colorectal cancer risk in Morocco: evidence from a nationally representative case-control study. Eur J Nutr. 61(5): 2507-2515. https://doi.org/10.1007/s00394-022-02820-3 PMID: 35211850
  289. Ellingjord-Dale M, Christakoudi S, Weiderpass E, Panico S, Dossus L, Olsen A, et al. (2022). Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol. 50(6): 1914-1926. https://doi.org/10.1093/ije/dyab032 PMID: 34999853
  290. Etievant L, Viallon V (2022). On some limitations of probabilistic models for dimension-reduction: Illustration in the case of probabilistic formulations of partial least squares. Statistica Neerlandica. 76(3): 331-346. https://doi.org/10.1111/stan.12262
  291. Etievant L, Viallon V (2022). Causal inference under over-simplified longitudinal causal models. Int J Biostat. 18(2): 421-437. https://doi.org/10.1515/ijb-2020-0081 PMID: 34727585
  292. Fiolet T, Casagrande C, Nicolas G, Horvath Z, Frenoy P, Weiderpass E, et al. (2022). Dietary intakes of dioxins and polychlorobiphenyls (PCBs) and breast cancer risk in 9 European countries. Environ Int. 163: 107213. https://doi.org/10.1016/j.envint.2022.107213 PMID: 35364416
  293. Flieh SM, Miguel-Berges ML, Huybrechts I, Castillo MJ, Gonzalez-Gross M, Marcos A, et al. (2022). Associations between food portion sizes, insulin resistance, VO2 max and metabolic syndrome in European adolescents: The HELENA study. Nutr Metab Cardiovasc Dis. 32(9): 2061-2073. https://doi.org/10.1016/j.numecd.2022.05.017 PMID: 35850749
  294. Fontvieille E, His M, Biessy C, Navionis AS, Torres-Mejia G, Angeles-Llerenas A, et al. (2022). Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study. BMC Cancer. 22(1): 877. https://doi.org/10.1186/s12885-022-09975-6 PMID: 35948877
  295. Gaziano L, Sun L, Arnold M, Bell S, Cho K, Kaptoge SK, et al. (2022). Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses. Circulation. 146(20): 1507-1517. https://doi.org/10.1161/CIRCULATIONAHA.122.060700 PMID: 36314129
  296. Georgeson P, Harrison TA, Pope BJ, Zaidi SH, Qu C, Steinfelder RS, et al. (2022). Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures. Nat Commun. 13(1): 3254. https://doi.org/10.1038/s41467-022-30916-1 PMID: 35668106
  297. Gil-Lespinard M, Castaneda J, Almanza-Aguilera E, Gomez JH, Tjonneland A, Kyro C, et al. (2022). Dietary Intake of 91 Individual Polyphenols and 5-Year Body Weight Change in the EPIC-PANACEA Cohort. Antioxidants (Basel). 11(12). https://doi.org/10.3390/antiox11122425 PMID: 36552633
  298. Goerdten J, Yuan L, Huybrechts I, Neveu V, Nothlings U, Ahrens W, et al. (2022). Reproducibility of the Blood and Urine Exposome: A Systematic Literature Review and Meta-Analysis. Cancer Epidemiol Biomarkers Prev. 31(9): 1683-1692. https://doi.org/10.1158/1055-9965.EPI-22-0090 PMID: 35732488
  299. Grenville ZS, Noor U, His M, Viallon V, Rinaldi S, Aglago EK, et al. (2022). Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer. Nutrients. 14(16): 3306. https://doi.org/10.3390/nu14163306 PMID: 36014812
  300. Gruzieva O, Jeong A, He S, Yu Z, de Bont J, Pinho MGM, et al. (2022). Air pollution, metabolites and respiratory health across the life-course. Eur Respir Rev. 31(165): 220038. https://doi.org/10.1183/16000617.0038-2022 PMID: 35948392
  301. Harbs J, Rinaldi S, Gicquiau A, Keski-Rahkonen P, Mori N, Liu X, et al. (2022). Circulating Sex Hormone Levels and Colon Cancer Risk in Men: A Nested Case-Control Study and Meta-Analysis. Cancer Epidemiol Biomarkers Prev. 31(4): 793-803. https://doi.org/10.1158/1055-9965.EPI-21-0996 PMID: 35086823
  302. Hardt L, Mahamat-Saleh Y, Aune D, Schlesinger S (2022). Plant-Based Diets and Cancer Prognosis: a Review of Recent Research. Curr Nutr Rep. 11(4): 695-716. https://doi.org/10.1007/s13668-022-00440-1 PMID: 36138327
  303. Harlid S, Van Guelpen B, Qu C, Gylling B, Aglago EK, Amitay EL, et al. (2022). Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases. Int J Cancer. 151(3): 348-360. https://doi.org/10.1002/ijc.34015 PMID: 35383926
  304. Hatime Z, El Kinany K, Huybrechts I, Murphy N, Gunter MJ, Khalis M, et al. (2022). Association of Physical Activity and Sedentary Behavior with Colorectal Cancer Risk in Moroccan Adults: A Large-Scale, Population-Based Case-Control Study. Asian Pac J Cancer Prev. 23(6): 1859-1866. https://doi.org/10.31557/APJCP.2022.23.6.1859 PMID: 35763624
  305. Hazelwood E, Sanderson E, Tan VY, Ruth KS, Frayling TM, Dimou N, et al. (2022). Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis. BMC Med. 20(1): 125. https://doi.org/10.1186/s12916-022-02322-3 PMID: 35436960
  306. Heath AK, Muller DC, van den Brandt PA, Critselis E, Gunter M, Vineis P, et al. (2022). Diet-wide association study of 92 foods and nutrients and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition study and the Netherlands Cohort Study. Int J Cancer. 151(11): 1935-1946. https://doi.org/10.1002/ijc.34211 PMID: 35830197
  307. Hoeylaerts S, Van Opstal A, Huybrechts I, Koppen G, Devlieger R, Godderis L, et al. (2022). Validation of a food-frequency questionnaire to assess methyl-group donor intake in preschoolers. Eur J Pediatr. 181(5): 1871-1881. https://doi.org/10.1007/s00431-021-04367-7 PMID: 35029741
  308. Huang Y, Hua X, Labadie JD, Harrison TA, Dai JY, Lindstrom S, et al. (2022). Genetic variants associated with circulating C-reactive protein levels and colorectal cancer survival: Sex-specific and lifestyle factors specific associations. Int J Cancer. 150(9): 1447-1454. https://doi.org/10.1002/ijc.33897 PMID: 34888857
  309. Huybrechts I, Rauber F, Nicolas G, Casagrande C, Kliemann N, Wedekind R, et al. (2022). Characterization of the degree of food processing in the European Prospective Investigation into Cancer and Nutrition: Application of the Nova classification and validation using selected biomarkers of food processing. Front Nutr. 9: 1035580. https://doi.org/10.3389/fnut.2022.1035580 PMID: 36590209
  310. Iglesias-Vazquez L, Arija V, Aranda N, Aglago EK, Cross AJ, Schulze MB, et al. (2022). Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study. Eur J Nutr. 61(1): 101-114. https://doi.org/10.1007/s00394-021-02625-w PMID: 34213605
  311. Iguacel I, Perez-Cornago A, Schmidt JA, Van Puyvelde H, Travis R, Casagrande C, et al. (2022). Evaluation of protein and amino acid intake estimates from the EPIC dietary questionnaires and 24-h dietary recalls using different food composition databases. Nutr Metab Cardiovasc Dis. 32(1): 80-89. https://doi.org/10.1016/j.numecd.2021.09.012 PMID: 34696945
  312. Jacobs I, Taljaard-Krugell C, Wicks M, Cubasch H, Joffe M, Laubscher R, et al. (2022). Adherence to cancer prevention recommendations is associated with a lower breast cancer risk in black urban South African women. Br J Nutr. 127(6): 927-938. https://doi.org/10.1017/S0007114521001598 PMID: 33988098
  313. Jacobs I, Taljaard-Krugell C, Wicks M, Cubasch H, Joffe M, Laubscher R, et al. (2022). Degree of food processing and breast cancer risk in black urban women from Soweto, South African: the South African Breast Cancer study. Br J Nutr. 128(11): 2278-2289. https://doi.org/10.1017/S0007114522000423 PMID: 35109954
  314. Jang HH, Noh H, Kim G, Cho SY, Kim HJ, Choe JS, et al. (2022). Differences in dietary patterns related to metabolic health by gut microbial enterotypes of Korean adults. Front Nutr. 9: 1045397. https://doi.org/10.3389/fnut.2022.1045397 PMID: 36687725
  315. Jordahl KM, Shcherbina A, Kim AE, Su YR, Lin Y, Wang J, et al. (2022). Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region. Cancer Epidemiol Biomarkers Prev. 31(5): 1077-1089. https://doi.org/10.1158/1055-9965.EPI-21-1003 PMID: 35438744
  316. Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A, et al. (2022). Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. Obesity (Silver Spring). 30(7): 1323-1334. https://doi.org/10.1002/oby.23444 PMID: 35785479
  317. Kelly RK, Pollard Z, Young H, Piernas C, Lentjes M, Mulligan A, et al. (2022). Evaluation of the New Individual Fatty Acid Dataset for UK Biobank: Analysis of Intakes and Sources in 207,997 Participants. Nutrients. 14(17): 3603. https://doi.org/10.3390/nu14173603 PMID: 36079862
  318. Kliemann N, Al Nahas A, Vamos EP, Touvier M, Kesse-Guyot E, Gunter MJ, et al. (2022). Ultra-processed foods and cancer risk: from global food systems to individual exposures and mechanisms. Br J Cancer. 127(1): 14-20. https://doi.org/10.1038/s41416-022-01749-y PMID: 35236935
  319. Kliemann N, Ould Ammar R, Biessy C, Gicquiau A, Katzke V, Kaaks R, et al. (2022). Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev. 31(7): 1359-1367. https://doi.org/10.1158/1055-9965.EPI-22-0160 PMID: 35437568
  320. Koelman L, Huybrechts I, Biesbroek S, van ‘t Veer P, Schulze MB, Aleksandrova K (2022). Dietary Choices Impact on Greenhouse Gas Emissions: Determinants and Correlates in a Sample of Adults from Eastern Germany. Sustainability. 14(7): 10. https://doi.org/10.3390/su14073854
  321. Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, et al. (2022). Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 22(1): 546. https://doi.org/10.1186/s12885-022-09589-y PMID: 35568802
  322. Labadie JD, Savas S, Harrison TA, Banbury B, Huang Y, Buchanan DD, et al. (2022). Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival. Sci Rep. 12(1): 127. https://doi.org/10.1038/s41598-021-03945-x PMID: 34996992
  323. Lecuyer L, Laouali N, Dossus L, Shivappa N, Hebert JR, Agudo A, et al. (2022). Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Eur J Nutr. 61(7): 3625-3635. https://doi.org/10.1007/s00394-022-02897-w PMID: 35635567
  324. Li C, Imamura F, Wedekind R, Stewart ID, Pietzner M, Wheeler E, et al. (2022). Development and validation of a metabolite score for red meat intake: an observational cohort study and randomized controlled dietary intervention. Am J Clin Nutr. 116(2): 511-522. https://doi.org/10.1093/ajcn/nqac094 PMID: 35754192
  325. Llaha F, Cayssials V, Farras M, Agudo A, Sandstrom M, Eriksen AK, et al. (2022). Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC study. Front Nutr. 9: 982369. https://doi.org/10.3389/fnut.2022.982369 PMID: 36118743
  326. Louca P, Nogal A, Moskal A, Goulding NJ, Shipley MJ, Alkis T, et al. (2022). Cross-Sectional Blood Metabolite Markers of Hypertension: A Multicohort Analysis of 44,306 Individuals from the COnsortium of METabolomics Studies. Metabolites. 12(7): 601. https://doi.org/10.3390/metabo12070601 PMID: 35888725
  327. Lu Y, Li G, Ferrari P, Freisling H, Qiao Y, Wu L, et al. (2022). Associations of handgrip strength with morbidity and all-cause mortality of cardiometabolic multimorbidity. BMC Med. 20(1): 191. https://doi.org/10.1186/s12916-022-02389-y PMID: 35655218
  328. Mariosa D, Smith-Byrne K, Richardson TG, Ferrari P, Gunter MJ, Papadimitriou N, et al. (2022). Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study. J Natl Cancer Inst. 114(9): 1296-1300. https://doi.org/10.1093/jnci/djac061 PMID: 35438160
  329. Martin S, Tyrrell J, Thomas EL, Bown MJ, Wood AR, Beaumont RN, et al. (2022). Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation. Elife. 11. https://doi.org/10.7554/eLife.72452 PMID: 35074047
  330. Matta M, Deubler E, Chajes V, Vozar B, Gunter MJ, Murphy N, et al. (2022). Circulating plasma phospholipid fatty acid levels and breast cancer risk in the Cancer Prevention Study-II Nutrition Cohort. Int J Cancer. 151(12): 2082-2094. https://doi.org/10.1002/ijc.34216 PMID: 35849437
  331. Mayen AL, Viallon V, Botteri E, Proust-Lima C, Bagnardi V, Batista V, et al. (2022). A longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk. Eur J Epidemiol. 37(9): 915-929. https://doi.org/10.1007/s10654-022-00900-6 PMID: 36063305
  332. Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I (2022). Human microbiome and metabolic health: An overview of systematic reviews. Obes Rev. 23(4): e13409. https://doi.org/10.1111/obr.13409 PMID: 34978141
  333. Mohammed Taha H, Aalizadeh R, Alygizakis N, Antignac JP, Arp HPH, Bade R, et al. (2022). The NORMAN Suspect List Exchange (NORMAN-SLE): facilitating European and worldwide collaboration on suspect screening in high resolution mass spectrometry. Environ Sci Eur. 34(1): 104. https://doi.org/10.1186/s12302-022-00680-6 PMID: 36284750
  334. Mohan A, Huybrechts I, Michels N (2022). Psychosocial stress and cancer risk: a narrative review. Eur J Cancer Prev. 31(6): 585-599. https://doi.org/10.1097/CEJ.0000000000000752 PMID: 35352705
  335. Mori N, Murphy N, Sawada N, Achaintre D, Yamaji T, Scalbert A, et al. (2022). Prediagnostic plasma polyphenol concentrations and colon cancer risk: The JPHC nested case-control study. Clin Nutr. 41(9): 1950-1960. https://doi.org/10.1016/j.clnu.2022.06.041 PMID: 35952597
  336. Mori N, Sawada N, Yamamoto J, Ishihara J, Shimazu T, Takachi R, et al. (2022). Validity of dietary isothiocyanate intake estimates from a food frequency questionnaire using 24 h urinary isothiocyanate excretion as an objective biomarker: the JPHC-NEXT protocol area. Eur J Clin Nutr. 76(3): 462-468. https://doi.org/10.1038/s41430-021-00970-x PMID: 34230632
  337. Mukama T, Fortner RT, Katzke V, Hynes LC, Petrera A, Hauck SM, et al. (2022). Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer. Br J Cancer. 126(9): 1301-1309. https://doi.org/10.1038/s41416-021-01697-z PMID: 35031764
  338. Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, et al. (2022). Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. J Natl Cancer Inst. 114(5): 740-752. https://doi.org/10.1093/jnci/djac011 PMID: 35048991
  339. Nimptsch K, Aleksandrova K, Fedirko V, Jenab M, Gunter MJ, Siersema PD, et al. (2022). Pre-diagnostic C-reactive protein concentrations, CRP genetic variation and mortality among individuals with colorectal cancer in Western European populations. BMC Cancer. 22(1): 695. https://doi.org/10.1186/s12885-022-09778-9 PMID: 35739525
  340. Pala V, Agnoli C, Cavalleri A, Rinaldi S, Orlandi R, Segrado F, et al. (2022). Prediagnostic Levels of Copper and Zinc and Breast Cancer Risk in the ORDET Cohort. Cancer Epidemiol Biomarkers Prev. 31(6): 1209-1215. https://doi.org/10.1158/1055-9965.EPI-21-1252 PMID: 35255128
  341. Papadimitriou N, Bouras E, van den Brandt PA, Muller DC, Papadopoulou A, Heath AK, et al. (2022). A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC. Clin Gastroenterol Hepatol. 20(4): 864-873 e813. https://doi.org/10.1016/j.cgh.2021.04.028 PMID: 33901663
  342. Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Reichmann R, Wu K, et al. (2022). Pre-Diagnostic Circulating Resistin Concentrations Are Not Associated with Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study. Cancers (Basel). 14(22): 5499. https://doi.org/10.3390/cancers14225499 PMID: 36428592
  343. Porta M, Gasull M, Pumarega J, Kiviranta H, Rantakokko P, Raaschou-Nielsen O, et al. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Int J Epidemiol. 51(2): 479-490. https://doi.org/10.1093/ije/dyab115 PMID: 34259837
  344. Robinson N, Casement J, Gunter MJ, Huybrechts I, Agudo A, Barranco MR, et al. (2022). Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors. Br J Cancer. 127(2): 288-300. https://doi.org/10.1038/s41416-022-01792-9 PMID: 35354948
  345. Roel E, Pistillo A, Recalde M, Fernandez-Bertolin S, Aragon M, Soerjomataram I, et al. (2022). Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. Int J Cancer. 150(5): 782-794. https://doi.org/10.1002/ijc.33846 PMID: 34655476
  346. Romieu I, Khandpur N, Katsikari A, Biessy C, Torres-Mejia G, Angeles-Llerenas A, et al. (2022). Consumption of industrial processed foods and risk of premenopausal breast cancer among Latin American women: the PRECAMA study. BMJ Nutr Prev Health. 5(1): 1-9. https://doi.org/10.1136/bmjnph-2021-000335 PMID: 35814719
  347. Rothwell JA, Jenab M, Karimi M, Truong T, Mahamat-Saleh Y, Ferrari P, et al. (2022). Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data. Clin Gastroenterol Hepatol. 20(6): e1338-e1352. https://doi.org/10.1016/j.cgh.2021.10.016 PMID: 34687971
  348. Rothwell JA, Mori N, Artaud F, Fournier A, Conte M, Boutron-Ruault MC, et al. (2022). Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies. Cancer Commun (Lond). 42(5): 486-489. https://doi.org/10.1002/cac2.12265 PMID: 35132829
  349. Rothwell JA, Murphy N, Besevic J, Kliemann N, Jenab M, Ferrari P, et al. (2022). Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort. Clin Gastroenterol Hepatol. 20(5): e1061-e1082. https://doi.org/10.1016/j.cgh.2020.11.045 PMID: 33279777
  350. Sahrai MS, Huybrechts I, Biessy C, Rinaldi S, Ferrari P, Wasiq AW, et al. (2022). Determinants of Obesity and Metabolic Health in the Afghan Population: Protocol, Methodology, and Preliminary Results. J Epidemiol Glob Health. 12(1): 113-123. https://doi.org/10.1007/s44197-021-00026-0 PMID: 34994966
  351. Salas S, Cottet V, Dossus L, Fassier P, Ginhac J, Latino-Martel P, et al. (2022). Nutritional Factors during and after Cancer: Impacts on Survival and Quality of Life. Nutrients. 14(14): 2958. https://doi.org/10.3390/nu14142958 PMID: 35889914
  352. Santaliestra-Pasias AM, Felez AP, Huybrechts I, Censi L, Gonzalez-Gross M, Forsner M, et al. (2022). Social Environment and Food and Beverage Intake in European Adolescents: The Helena Study. J Am Nutr Assoc. 41(5): 468-480. https://doi.org/10.1080/07315724.2021.1917462 PMID: 35512772
  353. Seyed Khoei N, Wagner KH, Sedlmeier AM, Gunter MJ, Murphy N, Freisling H (2022). Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank. Cardiovasc Diabetol. 21(1): 54. https://doi.org/10.1186/s12933-022-01484-x PMID: 35436955
  354. Seyyedsalehi MS, Collatuzzo G, Huybrechts I, Hadji M, Rashidian H, Safari-Faramani R, et al. (2022). Association between dietary fat intake and colorectal cancer: A multicenter case-control study in Iran. Front Nutr. 9: 1017720. https://doi.org/10.3389/fnut.2022.1017720 PMID: 36466398
  355. Seyyedsalehi MS, Collatuzzo G, Rashidian H, Hadji M, Gholipour M, Mohebbi E, et al. (2022). Dietary Ruminant and Industrial Trans-Fatty Acids Intake and Colorectal Cancer Risk. Nutrients. 14(22): 4912. https://doi.org/10.3390/nu14224912 PMID: 36432598
  356. Srour B, Chazelas E, Fezeu LK, Javaux G, Pierre F, Huybrechts I, et al. (2022). Nitrites, Nitrates, and Cardiovascular Outcomes: Are We Living “La Vie en Rose” With Pink Processed Meats? J Am Heart Assoc. 11(24): e027627. https://doi.org/10.1161/JAHA.122.027627 PMID: 36533633
  357. Stepien M, Lopez-Nogueroles M, Lahoz A, Kuhn T, Perlemuter G, Voican C, et al. (2022). Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma. Int J Cancer. 150(8): 1255-1268. https://doi.org/10.1002/ijc.33885 PMID: 34843121
  358. Tian Y, Kim AE, Bien SA, Lin Y, Qu C, Harrison TA, et al. (2022). Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk. J Natl Cancer Inst. 114(8): 1135-1148. https://doi.org/10.1093/jnci/djac094 PMID: 35512400
  359. Vissers LET, Sluijs I, Burgess S, Forouhi NG, Freisling H, Imamura F, et al. (2022). Milk intake and incident stroke and CHD in populations of European descent: a Mendelian randomisation study. Br J Nutr. 128(9): 1789-1797. https://doi.org/10.1017/S0007114521004244 PMID: 34670632
  360. Wang X, Kapoor PM, Auer PL, Dennis J, Dunning AM, Wang Q, et al. (2022). Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. Sci Rep. 12(1): 6199. https://doi.org/10.1038/s41598-022-10121-2 PMID: 35418701
  361. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. Int J Cancer. 151(7): 1033-1046. https://doi.org/10.1002/ijc.34116 PMID: 35579976
  362. Wedekind R, Rothwell JA, Viallon V, Keski-Rahkonen P, Schmidt JA, Chajes V, et al. (2022). Determinants of blood acylcarnitine concentrations in healthy individuals of the European Prospective Investigation into Cancer and Nutrition. Clin Nutr. 41(8): 1735-1745. https://doi.org/10.1016/j.clnu.2022.05.020 PMID: 35779425
  363. Wisnuwardani RW, De Henauw S, Forsner M, Gottrand F, Huybrechts I, Kafatos AG, et al. (2022). Adolescents’ dietary polyphenol intake in relation to serum total antioxidant capacity: the HELENA study. Int J Food Sci Nutr. 73(1): 71-81. https://doi.org/10.1080/09637486.2021.1910631 PMID: 33858286
  364. Yuan L, Muli S, Huybrechts I, Nothlings U, Ahrens W, Scalbert A, et al. (2022). Assessment of Fruit and Vegetables Intake with Biomarkers in Children and Adolescents and Their Level of Validation: A Systematic Review. Metabolites. 12(2). https://doi.org/10.3390/metabo12020126 PMID: 35208201
  365. Zouiouich S, Mariadassou M, Rue O, Vogtmann E, Huybrechts I, Severi G, et al. (2022). Comparison of Fecal Sample Collection Methods for Microbial Analysis Embedded within Colorectal Cancer Screening Programs. Cancer Epidemiol Biomarkers Prev. 31(2): 305-314. https://doi.org/10.1158/1055-9965.EPI-21-0188 PMID: 34782392
  366. Aglago EK, Mayen AL, Knaze V, Freisling H, Fedirko V, Hughes DJ, et al. (2021). Dietary Advanced Glycation End-Products and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Nutrients. 13(9). https://doi.org/10.3390/nu13093132 PMID: 34579010
  367. Aglago EK, Murphy N, Huybrechts I, Nicolas G, Casagrande C, Fedirko V, et al. (2021). Dietary intake and plasma phospholipid concentrations of saturated, monounsaturated and trans fatty acids and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Int J Cancer. 149(4): 865-882. https://doi.org/10.1002/ijc.33615 PMID: 33913149
  368. Aglago EK, Rinaldi S, Freisling H, Jiao L, Hughes DJ, Fedirko V, et al. (2021). Soluble Receptor for Advanced Glycation End-products (sRAGE) and Colorectal Cancer Risk: A Case-Control Study Nested within a European Prospective Cohort. Cancer Epidemiol Biomarkers Prev. 30(1): 182-192. https://doi.org/10.1158/1055-9965.EPI-20-0855 PMID: 33082206
  369. Aglago EK, Schalkwijk CG, Freisling H, Fedirko V, Hughes DJ, Jiao L, et al. (2021). Plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study. Carcinogenesis. 42(5): 705-713. https://doi.org/10.1093/carcin/bgab026 PMID: 33780524
  370. Aleksandrova K, Reichmann R, Kaaks R, Jenab M, Bueno-de-Mesquita HB, Dahm CC, et al. (2021). Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score. BMC Med. 19(1): 1. https://doi.org/10.1186/s12916-020-01826-0 PMID: 33390155
  371. Almanza-Aguilera E, Ceballos-Sanchez D, Achaintre D, Rothwell JA, Laouali N, Severi G, et al. (2021). Urinary Concentrations of (+)-Catechin and (-)-Epicatechin as Biomarkers of Dietary Intake of Flavan-3-ols in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Nutrients. 13(11): 14. https://doi.org/10.3390/nu13114157 PMID: 34836412
  372. Amadou A, Freisling H, Jenab M, Tsilidis KK, Trichopoulou A, Boffetta P, et al. (2021). Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium. Br J Cancer. 124(11): 1882-1890. https://doi.org/10.1038/s41416-021-01347-4 PMID: 33772152
  373. Archambault AN, Lin Y, Jeon J, Harrison TA, Bishop DT, Brenner H, et al. (2021). Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer. JNCI Cancer Spectr. 5(3): pkab029. https://doi.org/10.1093/jncics/pkab029 PMID: 34041438
  374. Baker JR, Umesh S, Jenab M, Schomburg L, Tjonneland A, Olsen A, et al. (2021). Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations. Biomedicines. 9(11). https://doi.org/10.3390/biomedicines9111521 PMID: 34829750
  375. Ballout N, Garcia C, Viallon V (2021). Sparse estimation for case-control studies with multiple disease subtypes. Biostatistics. 22(4): 738-755. https://doi.org/10.1093/biostatistics/kxz063 PMID: 31977036
  376. Barahona Ponce C, Scherer D, Brinster R, Boekstegers F, Marcelain K, Garate-Calderon V, et al. (2021). Gallstones, Body Mass Index, C-Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data. Hepatology. 73(5): 1783-1796. https://doi.org/10.1002/hep.31537 PMID: 32893372
  377. Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, et al. (2021). Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. Am J Hum Genet. 108(7): 1190-1203. https://doi.org/10.1016/j.ajhg.2021.05.013 PMID: 34146516
  378. Beghin L, Huybrechts I, Drumez E, Kersting M, Walker RW, Kafatos A, et al. (2021). High Fructose Intake Contributes to Elevated Diastolic Blood Pressure in Adolescent Girls: Results from The HELENA Study. Nutrients. 13(10): 14. https://doi.org/10.3390/nu13103608 PMID: 34684609
  379. Bondonno CP, Bondonno NP, Dalgaard F, Murray K, Gardener SL, Martins RN, et al. (2021). Flavonoid intake and incident dementia in the Danish Diet, Cancer, and Health cohort. Alzheimers Dement (N Y). 7(1): e12175. https://doi.org/10.1002/trc2.12175 PMID: 34027025
  380. Bondonno NP, Dalgaard F, Murray K, Davey RJ, Bondonno CP, Cassidy A, et al. (2021). Higher Habitual Flavonoid Intakes Are Associated with a Lower Incidence of Diabetes. J Nutr. 151(11): 3533-3542. https://doi.org/10.1093/jn/nxab269 PMID: 34313759
  381. Bondonno NP, Murray K, Cassidy A, Bondonno CP, Lewis JR, Croft KD, et al. (2021). Higher habitual flavonoid intakes are associated with a lower risk of peripheral artery disease hospitalizations. Am J Clin Nutr. 113(1): 187-199. https://doi.org/10.1093/ajcn/nqaa300 PMID: 33236045
  382. Butt J, Jenab M, Werner J, Fedirko V, Weiderpass E, Dahm CC, et al. (2021). Association of Pre-diagnostic Antibody Responses to Escherichia coli and Bacteroides fragilis Toxin Proteins with Colorectal Cancer in a European Cohort. Gut Microbes. 13(1): 1-14. https://doi.org/10.1080/19490976.2021.1903825 PMID: 33874856
  383. Cairat M, Al Rahmoun M, Gunter MJ, Heudel PE, Severi G, Dossus L, et al. (2021). Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women. BMC Med. 19(1): 186. https://doi.org/10.1186/s12916-021-02004-6 PMID: 34340701
  384. Cairat M, Al Rahmoun M, Gunter MJ, Severi G, Dossus L, Fournier A (2021). Antiplatelet Drug Use and Breast Cancer Risk in a Prospective Cohort of Postmenopausal Women. Cancer Epidemiol Biomarkers Prev. 30(4): 643-652. https://doi.org/10.1158/1055-9965.EPI-20-1292 PMID: 33531438
  385. Campbell PT, Lin Y, Bien SA, Figueiredo JC, Harrison TA, Guinter MA, et al. (2021). Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants. J Natl Cancer Inst. 113(1): 38-47. https://doi.org/10.1093/jnci/djaa058 PMID: 32324875
  386. Castro-Espin C, Agudo A, Bonet C, Katzke V, Turzanski-Fortner R, Aleksandrova K, et al. (2021). Inflammatory potential of the diet and risk of breast cancer in the European Investigation into Cancer and Nutrition (EPIC) study. Eur J Epidemiol. 36(9): 953-964. https://doi.org/10.1007/s10654-021-00772-2 PMID: 34148186
  387. Chaby LE, Lasseter HC, Contrepois K, Salek RM, Turck CW, Thompson A, et al. (2021). Cross-Platform Evaluation of Commercially Targeted and Untargeted Metabolomics Approaches to Optimize the Investigation of Psychiatric Disease. Metabolites. 11(9). https://doi.org/10.3390/metabo11090609 PMID: 34564425
  388. Chang K, Khandpur N, Neri D, Touvier M, Huybrechts I, Millett C, et al. (2021). Association Between Childhood Consumption of Ultraprocessed Food and Adiposity Trajectories in the Avon Longitudinal Study of Parents and Children Birth Cohort. JAMA Pediatr. 175(9): e211573. https://doi.org/10.1001/jamapediatrics.2021.1573 PMID: 34125152
  389. Charaka H, Khalis M, Elfakir S, Huybrechts I, Khazraji YC, Lyoussi B, et al. (2021). Knowledge, Perceptions, and Satisfaction of Moroccan Women Towards a New Breast Cancer Screening Program in Morocco. J Cancer Educ. 36(4): 657-663. https://doi.org/10.1007/s13187-019-01680-6 PMID: 31873856
  390. Chazelas E, Druesne-Pecollo N, Esseddik Y, de Edelenyi FS, Agaesse C, De Sa A, et al. (2021). Exposure to food additive mixtures in 106,000 French adults from the NutriNet-Sante cohort. Sci Rep. 11(1): 19680. https://doi.org/10.1038/s41598-021-98496-6 PMID: 34608173
  391. Chen SLF, Braaten T, Borch KB, Ferrari P, Sandanger TM, Nost TH (2021). Combined Lifestyle Behaviors and the Incidence of Common Cancer Types in the Norwegian Women and Cancer Study (NOWAC). Clin Epidemiol. 13: 721-734. https://doi.org/10.2147/CLEP.S312864 PMID: 34429658
  392. Christakoudi S, Pagoni P, Ferrari P, Cross AJ, Tzoulaki I, Muller DC, et al. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 148(7): 1637-1651. https://doi.org/10.1002/ijc.33339 PMID: 33038275
  393. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2021). A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 114(1): 338-347. https://doi.org/10.1093/ajcn/nqab045 PMID: 33829249
  394. Collaboration NCDRF (2021). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 10. https://doi.org/10.7554/eLife.60060 PMID: 33685583
  395. Collaboration NCDRF (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 398(10304): 957-980. https://doi.org/10.1016/S0140-6736(21)01330-1 PMID: 34450083
  396. Cordova R, Kliemann N, Huybrechts I, Rauber F, Vamos EP, Levy RB, et al. (2021). Consumption of ultra-processed foods associated with weight gain and obesity in adults: A multi-national cohort study. Clin Nutr. 40(9): 5079-5088. https://doi.org/10.1016/j.clnu.2021.08.009 PMID: 34455267
  397. Dagnino S, Bodinier B, Guida F, Smith-Byrne K, Petrovic D, Whitaker MD, et al. (2021). Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer. Cancer Res. 81(13): 3738-3748. https://doi.org/10.1158/0008-5472.CAN-20-3454 PMID: 33574093
  398. Dashti SG, English DR, Simpson JA, Karahalios A, Moreno-Betancur M, Biessy C, et al. (2021). Adiposity and Endometrial Cancer Risk in Postmenopausal Women: A Sequential Causal Mediation Analysis. Cancer Epidemiol Biomarkers Prev. 30(1): 104-113. https://doi.org/10.1158/1055-9965.EPI-20-0965 PMID: 33008875
  399. Dessinioti C, Geller AC, Stergiopoulou A, Dimou N, Lo S, Keim U, et al. (2021). A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences. Br J Dermatol. 185(1): 101-109. https://doi.org/10.1111/bjd.19819 PMID: 33454993
  400. Dianatinasab M, Wesselius A, de Loeij T, Salehi-Abargouei A, Yu EYW, Fararouei M, et al. (2021). The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies. Eur J Epidemiol. 36(8): 781-792. https://doi.org/10.1007/s10654-021-00762-4 PMID: 34036467
  401. Dimou N, Mori N, Harlid S, Harbs J, Martin RM, Smith-Byrne K, et al. (2021). Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 30(7): 1336-1348. https://doi.org/10.1158/1055-9965.EPI-20-1690 PMID: 33879453
  402. Dimou N, Yarmolinsky J, Bouras E, Tsilidis KK, Martin RM, Lewis SJ, et al. (2021). Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev. 30(5): 953-964. https://doi.org/10.1158/1055-9965.EPI-20-1218 PMID: 33653810
  403. Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, et al. (2021). Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. Int J Cancer. 148(7): 1625-1636. https://doi.org/10.1002/ijc.33338 PMID: 33038280
  404. Dossus L, Kouloura E, Biessy C, Viallon V, Siskos AP, Dimou N, et al. (2021). Prospective analysis of circulating metabolites and endometrial cancer risk. Gynecol Oncol. 162(2): 475-481. https://doi.org/10.1016/j.ygyno.2021.06.001 PMID: 34099314
  405. El Abiead Y, Milford M, Salek RM, Koellensperger G (2021). mzRAPP – A tool for reliability assessment of data pre-processing in non-targeted metabolomics. Bioinformatics. 37(20): 3678-3680. https://doi.org/10.1093/bioinformatics/btab231 PMID: 33826687
  406. Ellingjord-Dale M, Papadimitriou N, Katsoulis M, Yee C, Dimou N, Gill D, et al. (2021). Coffee consumption and risk of breast cancer: A Mendelian randomization study. PLoS One. 16(1): e0236904. https://doi.org/10.1371/journal.pone.0236904 PMID: 33465101
  407. Flieh SM, Miguel-Berges ML, Gonzalez-Gil EM, Gottrand F, Censi L, Widhalm K, et al. (2021). The Association between Portion Sizes from High-Energy-Dense Foods and Body Composition in European Adolescents: The HELENA Study. Nutrients. 13(3). https://doi.org/10.3390/nu13030954 PMID: 33809476
  408. Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de Gonzalez A, et al. (2021). Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. Cancer Res. 81(8): 2246-2255. https://doi.org/10.1158/0008-5472.CAN-19-3093 PMID: 33820799
  409. Gbenonsi G, Boucham M, Belrhiti Z, Nejjari C, Huybrechts I, Khalis M (2021). Health system factors that influence diagnostic and treatment intervals in women with breast cancer in sub-Saharan Africa: a systematic review. BMC Public Health. 21(1): 1325. https://doi.org/10.1186/s12889-021-11296-5 PMID: 34229634
  410. Geijsen A, Kok DE, van Zutphen M, Keski-Rahkonen P, Achaintre D, Gicquiau A, et al. (2021). Diet quality indices and dietary patterns are associated with plasma metabolites in colorectal cancer patients. Eur J Nutr. 60(6): 3171-3184. https://doi.org/10.1007/s00394-021-02488-1 PMID: 33544207
  411. Genua F, Raghunathan V, Jenab M, Gallagher WM, Hughes DJ (2021). The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development. Front Oncol. 11: 626349. https://doi.org/10.3389/fonc.2021.626349 PMID: 33937029
  412. Georgiou AN, Ntritsos G, Papadimitriou N, Dimou N, Evangelou E (2021). Cigarette Smoking, Coffee Consumption, Alcohol Intake, and Risk of Crohn’s Disease and Ulcerative Colitis: A Mendelian Randomization Study. Inflamm Bowel Dis. 27(2): 162-168. https://doi.org/10.1093/ibd/izaa152 PMID: 32628751
  413. Gonzalez-Gil EM, Huybrechts I, Aguilera CM, Beghin L, Breidenassel C, Gesteiro E, et al. (2021). Cardiometabolic Risk is Positively Associated with Underreporting and Inversely Associated with Overreporting of Energy Intake Among European Adolescents: The Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) Study. J Nutr. 151(3): 675-684. https://doi.org/10.1093/jn/nxaa389 PMID: 33484148
  414. group Sw, collaboration ESCCr (2021). SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 42(25): 2439-2454. https://doi.org/10.1093/eurheartj/ehab309 PMID: 34120177
  415. Guida F, Tan VY, Corbin LJ, Smith-Byrne K, Alcala K, Langenberg C, et al. (2021). The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 18(9): e1003786. https://doi.org/10.1371/journal.pmed.1003786 PMID: 34543281
  416. Gumpenberger T, Brezina S, Keski-Rahkonen P, Baierl A, Robinot N, Leeb G, et al. (2021). Untargeted Metabolomics Reveals Major Differences in the Plasma Metabolome between Colorectal Cancer and Colorectal Adenomas. Metabolites. 11(2). https://doi.org/10.3390/metabo11020119 PMID: 33669644
  417. Guo X, Lin W, Wen W, Huyghe J, Bien S, Cai Q, et al. (2021). Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects. Gastroenterology. 160(4): 1164-1178 e1166. https://doi.org/10.1053/j.gastro.2020.08.062 PMID: 33058866
  418. Hana CA, Tran LV, Molzer C, Mullner E, Hormann-Wallner M, Franzke B, et al. (2021). Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert’s syndrome individuals. Metabolism. 125: 154913. https://doi.org/10.1016/j.metabol.2021.154913 PMID: 34653509
  419. Handakas E, Keski-Rahkonen P, Chatzi L, Alfano R, Roumeliotaki T, Plusquin M, et al. (2021). Cord blood metabolic signatures predictive of childhood overweight and rapid growth. Int J Obes (Lond). 45(10): 2252-2260. https://doi.org/10.1038/s41366-021-00888-1 PMID: 34253844
  420. Hanley-Cook GT, Huybrechts I, Biessy C, Remans R, Kennedy G, Deschasaux-Tanguy M, et al. (2021). Food biodiversity and total and cause-specific mortality in 9 European countries: An analysis of a prospective cohort study. PLoS Med. 18(10): e1003834. https://doi.org/10.1371/journal.pmed.1003834 PMID: 34662340
  421. Harlid S, Gunter MJ, Van Guelpen B (2021). Risk-Predictive and Diagnostic Biomarkers for Colorectal Cancer; a Systematic Review of Studies Using Pre-Diagnostic Blood Samples Collected in Prospective Cohorts and Screening Settings. Cancers (Basel). 13(17). https://doi.org/10.3390/cancers13174406 PMID: 34503217
  422. Harlid S, Harbs J, Myte R, Brunius C, Gunter MJ, Palmqvist R, et al. (2021). A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk. Sci Rep. 11(1): 5151. https://doi.org/10.1038/s41598-021-83968-6 PMID: 33664295
  423. Hatime Z, El Kinany K, Huybrechts I, Gunter MJ, Khalis M, Deoula M, et al. (2021). Extended healthy lifestyle index and colorectal cancer risk in the Moroccan population. Eur J Nutr. 60(2): 1013-1022. https://doi.org/10.1007/s00394-020-02311-3 PMID: 32572618
  424. Heath AK, Clasen JL, Jayanth NP, Jenab M, Tjonneland A, Petersen KEN, et al. (2021). Soft Drink and Juice Consumption and Renal Cell Carcinoma Incidence and Mortality in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 30(6): 1270-1274. https://doi.org/10.1158/1055-9965.EPI-20-1726 PMID: 33849969
  425. His M, Lajous M, Gomez-Flores-Ramos L, Monge A, Dossus L, Viallon V, et al. (2021). Biomarkers of mammographic density in premenopausal women. Breast Cancer Res. 23(1): 75. https://doi.org/10.1186/s13058-021-01454-3 PMID: 34301304
  426. His M, Viallon V, Dossus L, Schmidt JA, Travis RC, Gunter MJ, et al. (2021). Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort. BMC Med. 19(1): 312. https://doi.org/10.1186/s12916-021-02183-2 PMID: 34886862
  427. Hua X, Dai JY, Lindstrom S, Harrison TA, Lin Y, Alberts SR, et al. (2021). Genetically Predicted Circulating C-Reactive Protein Concentration and Colorectal Cancer Survival: A Mendelian Randomization Consortium Study. Cancer Epidemiol Biomarkers Prev. 30(7): 1349-1358. https://doi.org/10.1158/1055-9965.EPI-20-1848 PMID: 33972368
  428. Huybrechts I, Kliemann N, Perol O, Cattey-Javouhey A, Benech N, Maire A, et al. (2021). Feasibility Study to Assess the Impact of a Lifestyle Intervention during Colorectal Cancer Screening in France. Nutrients. 13(11). https://doi.org/10.3390/nu13113685 PMID: 34835941
  429. Huybrechts I, Miglio R, Mistura L, Grioni S, Pozzebon I, Odorifero C, et al. (2021). Relative Validity of an Italian EPIC Food Frequency Questionnaire for Dietary Factors in Children and Adolescents. A Rizzoli Orthopedic Institute Study. Nutrients. 13(4). https://doi.org/10.3390/nu13041245 PMID: 33918879
  430. Huyghe JR, Harrison TA, Bien SA, Hampel H, Figueiredo JC, Schmit SL, et al. (2021). Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. 70(7): 1325-1334. https://doi.org/10.1136/gutjnl-2020-321534 PMID: 33632709
  431. Iguacel I, Bornhorst C, Michels N, Breidenassel C, Dallongeville J, Gonzalez-Gross M, et al. (2021). Socioeconomically Disadvantaged Groups and Metabolic Syndrome in European Adolescents: The HELENA Study. J Adolesc Health. 68(1): 146-154. https://doi.org/10.1016/j.jadohealth.2020.05.027 PMID: 32636143
  432. Iguacel I, Huybrechts I, Moreno LA, Michels N (2021). Vegetarianism and veganism compared with mental health and cognitive outcomes: a systematic review and meta-analysis. Nutr Rev. 79(4): 361-381. https://doi.org/10.1093/nutrit/nuaa030 PMID: 32483598
  433. Iguacel I, Schmidt JA, Perez-Cornago A, Van Puyvelde H, Travis R, Stepien M, et al. (2021). Associations between dietary amino acid intakes and blood concentration levels. Clin Nutr. 40(6): 3772-3779. https://doi.org/10.1016/j.clnu.2021.04.036 PMID: 34130023
  434. Jacobs I, Taljaard-Krugell C, Wicks M, Badham JM, Cubasch H, Joffe M, et al. (2021). Adherence to the South African food based dietary guidelines may reduce breast cancer risk in black South African women: the South African Breast Cancer (SABC) study. Public Health Nutr. 25(10): 1-17. https://doi.org/10.1017/S1368980021004675 PMID: 34839846
  435. Jacobs I, Taljaard-Krugell C, Wicks M, Cubasch H, Joffe M, Laubscher R, et al. (2021). Dietary Patterns and Breast Cancer Risk in Black Urban South African Women: The SABC Study. Nutrients. 13(11): 4106. https://doi.org/10.3390/nu13114106 PMID: 34836361
  436. Jafri A, Mathe N, Aglago EK, Konyole SO, Ouedraogo M, Audain K, et al. (2021). Food availability, accessibility and dietary practices during the COVID-19 pandemic: a multi-country survey. Public Health Nutr. 24(7): 1798-1805. https://doi.org/10.1017/S1368980021000987 PMID: 33663623
  437. Jayasekara H, MacInnis RJ, Lujan-Barroso L, Mayen-Chacon AL, Cross AJ, Wallner B, et al. (2021). Lifetime alcohol intake, drinking patterns over time and risk of stomach cancer: A pooled analysis of data from two prospective cohort studies. Int J Cancer. 148(11): 2759-2773. https://doi.org/10.1002/ijc.33504 PMID: 33554339
  438. Jobard E, Dossus L, Baglietto L, Fornili M, Lecuyer L, Mancini FR, et al. (2021). Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort. Br J Cancer. 124(10): 1734-1743. https://doi.org/10.1038/s41416-021-01304-1 PMID: 33723391
  439. Karabegovic I, Portilla-Fernandez E, Li Y, Ma J, Maas SCE, Sun D, et al. (2021). Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption. Nat Commun. 12(1): 2830. https://doi.org/10.1038/s41467-021-22752-6 PMID: 33990564
  440. Katzke VA, Le Cornet C, Mahfouz R, Brauer B, Johnson T, Canzian F, et al. (2021). Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures. Cancer Epidemiol Biomarkers Prev. 30(12): 2179-2187. https://doi.org/10.1158/1055-9965.EPI-21-0169 PMID: 34548327
  441. Keski-Rahkonen P, Robinson O, Alfano R, Plusquin M, Scalbert A (2021). Commentary: Data Processing Thresholds for Abundance and Sparsity and Missed Biological Insights in an Untargeted Chemical Analysis of Blood Specimens for Exposomics. Front Public Health. 9: 755837. https://doi.org/10.3389/fpubh.2021.755837 PMID: 35111711
  442. Kliemann N, Viallon V, Murphy N, Beeken RJ, Rothwell JA, Rinaldi S, et al. (2021). Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 19(1): 101. https://doi.org/10.1186/s12916-021-01970-1 PMID: 33926456
  443. Kontou P, Pavlopoulou A, Dimou N, Theodoropoulou M, Braliou G, Tsaousis G, et al. (2021). The human GPCR signal transduction network. Network Modeling and Analysis in Health Informatics and Bioinformatics. 10(1): 12. https://doi.org/10.1007/s13721-020-00278-z PMID: WOS:000607861100001
  444. Laine JE, Huybrechts I, Gunter MJ, Ferrari P, Weiderpass E, Tsilidis K, et al. (2021). Co-benefits from sustainable dietary shifts for population and environmental health: an assessment from a large European cohort study. Lancet Planet Health. 5(11): e786-e796. https://doi.org/10.1016/S2542-5196(21)00250-3 PMID: 34688354
  445. Lamurias A, Jesus S, Neveu V, Salek RM, Couto FM (2021). Information Retrieval Using Machine Learning for Biomarker Curation in the Exposome-Explorer. Front Res Metr Anal. 6: 689264. https://doi.org/10.3389/frma.2021.689264 PMID: 34490412
  446. Laskar RS, Li P, Ecsedi S, Abedi-Ardekani B, Durand G, Robinot N, et al. (2021). Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma. Hum Mol Genet. 30(5): 343-355. https://doi.org/10.1093/hmg/ddab031 PMID: 33527138
  447. Li SX, Hodge AM, MacInnis RJ, Bassett JK, Ueland PM, Midttun O, et al. (2021). Inflammation-Related Marker Profiling of Dietary Patterns and All-cause Mortality in the Melbourne Collaborative Cohort Study. J Nutr. 151(10): 2908-2916. https://doi.org/10.1093/jn/nxab231 PMID: 34320210
  448. Linseisen J, Grundmann N, Zoller D, Kuhn T, Jansen E, Chajes V, et al. (2021). Red Blood Cell Fatty Acids and Risk of Colorectal Cancer in The European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev. 30(5): 874-885. https://doi.org/10.1158/1055-9965.EPI-20-1426 PMID: 33619024
  449. Loftfield E, Stepien M, Viallon V, Trijsburg L, Rothwell JA, Robinot N, et al. (2021). Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality. J Natl Cancer Inst. 113(11): 1542-1550. https://doi.org/10.1093/jnci/djab078 PMID: 34010397
  450. Londono C, Cayssials V, de Villasante I, Crous-Bou M, Scalbert A, Weiderpass E, et al. (2021). Polyphenol Intake and Epithelial Ovarian Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Antioxidants (Basel). 10(8). https://doi.org/10.3390/antiox10081249 PMID: 34439497
  451. Lopez de Maturana E, Rodriguez JA, Alonso L, Lao O, Molina-Montes E, Martin-Antoniano IA, et al. (2021). A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 13(1): 15. https://doi.org/10.1186/s13073-020-00816-4 PMID: 33517887
  452. Malfliet A, Quiroz Marnef A, Nijs J, Clarys P, Huybrechts I, Elma O, et al. (2021). Obesity Hurts: The Why and How of Integrating Weight Reduction With Chronic Pain Management. Phys Ther. 101(11). https://doi.org/10.1093/ptj/pzab198 PMID: 34403478
  453. Mao Z, Aglago EK, Zhao Z, Schalkwijk C, Jiao L, Freisling H, et al. (2021). Dietary Intake of Advanced Glycation End Products (AGEs) and Mortality among Individuals with Colorectal Cancer. Nutrients. 13(12): 4435. https://doi.org/10.3390/nu13124435 PMID: 34959986
  454. Matta M, Huybrechts I, Biessy C, Casagrande C, Yammine S, Fournier A, et al. (2021). Dietary intake of trans fatty acids and breast cancer risk in 9 European countries. BMC Med. 19(1): 81. https://doi.org/10.1186/s12916-021-01952-3 PMID: 33781249
  455. Mayen AL, Aglago EK, Knaze V, Cordova R, Schalkwijk CG, Wagner KH, et al. (2021). Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study. Int J Cancer. 149(4): 854-864. https://doi.org/10.1002/ijc.33612 PMID: 33899229
  456. Medina C, Monge A, Romero M, Lopez-Ridaura R, Barquera S, Romieu I, et al. (2021). Reliability and validity of the Mexican teachers’ physical activity questionnaire (MTPAQ) in a subsample of female Mexican teachers. BMC Sports Sci Med Rehabil. 13(1): 143. https://doi.org/10.1186/s13102-021-00371-4 PMID: 34758874
  457. Merritt MA, Strickler HD, Hutson AD, Einstein MH, Rohan TE, Xue X, et al. (2021). Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer. Cancer Epidemiol Biomarkers Prev. 30(4): 719-726. https://doi.org/10.1158/1055-9965.EPI-20-1613 PMID: 33622671
  458. Michels N, De Backer F, Dimakopoulou M, Mane K, Indave I, Huybrechts I (2021). Eating disorders and the risk of developing cancer: a systematic review. Eat Weight Disord. 26(4): 1021-1035. https://doi.org/10.1007/s40519-020-01020-4 PMID: 33025526
  459. Michels N, Specht IO, Heitmann BL, Chajes V, Huybrechts I (2021). Dietary trans-fatty acid intake in relation to cancer risk: a systematic review and meta-analysis. Nutr Rev. 79(7): 758-776. https://doi.org/10.1093/nutrit/nuaa061 PMID: 34104953
  460. Michels N, van Aart C, Morisse J, Mullee A, Huybrechts I (2021). Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies. Crit Rev Oncol Hematol. 157: 103177. https://doi.org/10.1016/j.critrevonc.2020.103177 PMID: 33264718
  461. Mori N, Keski-Rahkonen P, Gicquiau A, Rinaldi S, Dimou N, Harlid S, et al. (2021). Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis. JNCI Cancer Spectr. 5(6): 10. https://doi.org/10.1093/jncics/pkab084 PMID: 34805742
  462. Mori N, Sawada N, Ishihara J, Kotemori A, Takachi R, Murai U, et al. (2021). Validity of a food frequency questionnaire for the estimation of total polyphenol intake estimates and its major food sources in the Japanese population: the JPHC FFQ Validation Study. J Nutr Sci. 10: e35. https://doi.org/10.1017/jns.2021.25 PMID: 34094515
  463. Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, et al. (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Res. 23(1): 86. https://doi.org/10.1186/s13058-021-01450-7 PMID: 34407845
  464. Mullee A, Dimou N, Allen N, O’Mara T, Gunter MJ, Murphy N (2021). Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses. Br J Cancer. 125(9): 1308-1317. https://doi.org/10.1038/s41416-021-01518-3 PMID: 34363033
  465. Murphy N, Campbell PT, Gunter MJ (2021). Unraveling the Etiology of Early-Onset Colorectal Cancer. J Natl Cancer Inst. 113(5): 505-506. https://doi.org/10.1093/jnci/djaa165 PMID: 33136122
  466. Murphy N, Campbell PT, Gunter MJ (2021). Are sugar-sweetened beverages contributing to the rising occurrence of colorectal cancer in young adults? Gut. 70(12): 2222-2223. https://doi.org/10.1136/gutjnl-2021-324614 PMID: 34016645
  467. Noh H, Jang HH, Kim G, Zouiouich S, Cho SY, Kim HJ, et al. (2021). Taxonomic Composition and Diversity of the Gut Microbiota in Relation to Habitual Dietary Intake in Korean Adults. Nutrients. 13(2): 366. https://doi.org/10.3390/nu13020366 PMID: 33530330
  468. Nounu A, Greenhough A, Heesom KJ, Richmond RC, Zheng J, Weinstein SJ, et al. (2021). A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 30(3): 564-575. https://doi.org/10.1158/1055-9965.EPI-20-1176 PMID: 33318029
  469. Nounu A, Richmond RC, Stewart ID, Surendran P, Wareham NJ, Butterworth A, et al. (2021). Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study. Nutrients. 13(11): 21. https://doi.org/10.3390/nu13114164 PMID: 34836419
  470. Ose J, Gigic B, Brezina S, Lin T, Baierl A, Geijsen A, et al. (2021). Targeted Plasma Metabolic Profiles and Risk of Recurrence in Stage II and III Colorectal Cancer Patients: Results from an International Cohort Consortium. Metabolites. 11(3). https://doi.org/10.3390/metabo11030129 PMID: 33668370
  471. Outzen M, Tjonneland A, Hughes DJ, Jenab M, Frederiksen K, Schomburg L, et al. (2021). Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study. Int J Cancer. 148(4): 876-883. https://doi.org/10.1002/ijc.33267 PMID: 32838475
  472. Papadimitriou N, Dimou N, Gill D, Tzoulaki I, Murphy N, Riboli E, et al. (2021). Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: A Mendelian randomization study. Int J Cancer. 148(3): 646-653. https://doi.org/10.1002/ijc.33246 PMID: 32761610
  473. Papadimitriou N, Gunter MJ, Murphy N, Gicquiau A, Achaintre D, Brezina S, et al. (2021). Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies. Int J Cancer. 149(9): 1659-1669. https://doi.org/10.1002/ijc.33725 PMID: 34196970
  474. Papadimitriou N, Markozannes G, Kanellopoulou A, Critselis E, Alhardan S, Karafousia V, et al. (2021). An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites. Nat Commun. 12(1): 4579. https://doi.org/10.1038/s41467-021-24861-8 PMID: 34321471
  475. Parmenter BH, Dalgaard F, Murray K, Cassidy A, Bondonno CP, Lewis JR, et al. (2021). Habitual flavonoid intake and ischemic stroke incidence in the Danish Diet, Cancer, and Health Cohort. Am J Clin Nutr. 114(1): 348-357. https://doi.org/10.1093/ajcn/nqab138 PMID: 33963737
  476. Pearson-Stuttard J, Papadimitriou N, Markozannes G, Cividini S, Kakourou A, Gill D, et al. (2021). Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies. Cancer Epidemiol Biomarkers Prev. 30(6): 1218-1228. https://doi.org/10.1158/1055-9965.EPI-20-1245 PMID: 33737302
  477. Peters S, Broberg K, Gallo V, Levi M, Kippler M, Vineis P, et al. (2021). Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort. Ann Neurol. 89(1): 125-133. https://doi.org/10.1002/ana.25932 PMID: 33068316
  478. Raglan O, MacIntyre DA, Mitra A, Lee YS, Smith A, Assi N, et al. (2021). The association between obesity and weight loss after bariatric surgery on the vaginal microbiota. Microbiome. 9(1): 124. https://doi.org/10.1186/s40168-021-01011-2 PMID: 34049596
  479. Recalde M, Davila-Batista V, Diaz Y, Leitzmann M, Romieu I, Freisling H, et al. (2021). Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med. 19(1): 10. https://doi.org/10.1186/s12916-020-01877-3 PMID: 33441148
  480. Recalde M, Pistillo A, Fernandez-Bertolin S, Roel E, Aragon M, Freisling H, et al. (2021). Body Mass Index and Risk of COVID-19 Diagnosis, Hospitalization, and Death: A Cohort Study of 2 524 926 Catalans. J Clin Endocrinol Metab. 106(12): e5030-e5042. https://doi.org/10.1210/clinem/dgab546 PMID: 34297116
  481. Ried-Larsen M, Rasmussen MG, Blond K, Overvad TF, Overvad K, Steindorf K, et al. (2021). Association of Cycling With All-Cause and Cardiovascular Disease Mortality Among Persons With Diabetes: The European Prospective Investigation Into Cancer and Nutrition (EPIC) Study. JAMA Intern Med. 181(9): 1196-1205. https://doi.org/10.1001/jamainternmed.2021.3836 PMID: 34279548
  482. Romieu I, Biessy C, Joffe M, Cubasch H, Norris S, Vorster HH, et al. (2021). Reproductive factors and risk of breast cancer in black South African women. Cancer Causes Control. 32(4): 415-422. https://doi.org/10.1007/s10552-021-01390-9 PMID: 33471235
  483. Rumgay H, Murphy N, Ferrari P, Soerjomataram I (2021). Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients. 13(9). https://doi.org/10.3390/nu13093173 PMID: 34579050
  484. Saberi Hosnijeh F, Casabonne D, Nieters A, Solans M, Naudin S, Ferrari P, et al. (2021). Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 148(9): 2115-2128. https://doi.org/10.1002/ijc.33369 PMID: 33128820
  485. Schmidt JA, Fensom GK, Rinaldi S, Scalbert A, Gunter MJ, Holmes MV, et al. (2021). NMR Metabolite Profiles in Male Meat-Eaters, Fish-Eaters, Vegetarians and Vegans, and Comparison with MS Metabolite Profiles. Metabolites. 11(2). https://doi.org/10.3390/metabo11020121 PMID: 33672542
  486. Seyed Khoei N, Carreras-Torres R, Murphy N, Gunter MJ, Brennan P, Smith-Byrne K, et al. (2021). Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells. 10(2). https://doi.org/10.3390/cells10020394 PMID: 33671849
  487. Seyed Khoei N, Wagner KH, Carreras-Torres R, Gunter MJ, Murphy N, Freisling H (2021). Associations between Prediagnostic Circulating Bilirubin Levels and Risk of Gastrointestinal Cancers in the UK Biobank. Cancers (Basel). 13(11): 15. https://doi.org/10.3390/cancers13112749 PMID: 34206031
  488. Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C (2021). Visceral obesity and incident cancer and cardiovascular disease: An integrative review of the epidemiological evidence. Obes Rev. 22(1): e13088. https://doi.org/10.1111/obr.13088 PMID: 32692447
  489. Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, et al. (2021). Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 375: n2233. https://doi.org/10.1136/bmj.n2233 PMID: 34702754
  490. Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. (2021). Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA. 326(16): 1614-1621. https://doi.org/10.1001/jama.2021.18236 PMID: 34698778
  491. Stepien M, Keski-Rahkonen P, Kiss A, Robinot N, Duarte-Salles T, Murphy N, et al. (2021). Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study. Int J Cancer. 148(3): 609-625. https://doi.org/10.1002/ijc.33236 PMID: 32734650
  492. Steur M, Johnson L, Sharp SJ, Imamura F, Sluijs I, Key TJ, et al. (2021). Dietary Fatty Acids, Macronutrient Substitutions, Food Sources and Incidence of Coronary Heart Disease: Findings From the EPIC-CVD Case-Cohort Study Across Nine European Countries. J Am Heart Assoc. 10(23): e019814. https://doi.org/10.1161/JAHA.120.019814 PMID: 34796724
  493. Thomas M, Sakoda LC, Hoffmeister M, Rosenthal EA, Lee JK, van Duijnhoven FJB, et al. (2021). Response to Li and Hopper. Am J Hum Genet. 108(3): 527-529. https://doi.org/10.1016/j.ajhg.2021.02.003 PMID: 33667396
  494. Thompson HJ, Levitt JO, McGinley JN, Chandler P, Guenther PM, Huybrechts I, et al. (2021). Measuring Dietary Botanical Diversity as a Proxy for Phytochemical Exposure. Nutrients. 13(4). https://doi.org/10.3390/nu13041295 PMID: 33919845
  495. Tsilidis KK, Papadimitriou N, Dimou N, Gill D, Lewis SJ, Martin RM, et al. (2021). Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study. Am J Clin Nutr. 113(6): 1490-1502. https://doi.org/10.1093/ajcn/nqab003 PMID: 33740060
  496. Van Puyvelde H, Papadimitriou N, Clasen J, Muller D, Biessy C, Ferrari P, et al. (2021). Dietary Methyl-Group Donor Intake and Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Nutrients. 13(6): 15. https://doi.org/10.3390/nu13061843 PMID: 34071317
  497. van Roekel EH, Bours MJL, van Delden L, Breukink SO, Aquarius M, Keulen ETP, et al. (2021). Longitudinal associations of physical activity with plasma metabolites among colorectal cancer survivors up to 2 years after treatment. Sci Rep. 11(1): 13738. https://doi.org/10.1038/s41598-021-92279-9 PMID: 34215757
  498. Viallon V, His M, Rinaldi S, Breeur M, Gicquiau A, Hemon B, et al. (2021). A New Pipeline for the Normalization and Pooling of Metabolomics Data. Metabolites. 11(9). https://doi.org/10.3390/metabo11090631 PMID: 34564446
  499. Vineis P, Huybrechts I, Millett C, Weiderpass E (2021). Climate change and cancer: converging policies. Mol Oncol. 15(3): 764-769. https://doi.org/10.1002/1878-0261.12781 PMID: 32964631
  500. Vlaanderen J, de Hoogh K, Hoek G, Peters A, Probst-Hensch N, Scalbert A, et al. (2021). Developing the building blocks to elucidate the impact of the urban exposome on cardiometabolic-pulmonary disease: The EU EXPANSE project. Environ Epidemiol. 5(4): e162. https://doi.org/10.1097/EE9.0000000000000162 PMID: 34414346
  501. Wang X, Amitay E, Harrison TA, Banbury BL, Berndt SI, Brenner H, et al. (2021). Association Between Smoking and Molecular Subtypes of Colorectal Cancer. JNCI Cancer Spectr. 5(4): 10. https://doi.org/10.1093/jncics/pkab056 PMID: 34377935
  502. Watts EL, Fensom GK, Smith Byrne K, Perez-Cornago A, Allen NE, Knuppel A, et al. (2021). Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank. Int J Cancer. 148(9): 2274-2288. https://doi.org/10.1002/ijc.33416 PMID: 33252839
  503. Wedekind R, Keski-Rahkonen P, Robinot N, Viallon V, Rothwell JA, Boutron-Ruault MC, et al. (2021). Pepper Alkaloids and Processed Meat Intake: Results from a Randomized Trial and the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Mol Nutr Food Res. 65(7): e2001141. https://doi.org/10.1002/mnfr.202001141 PMID: 33592132
  504. Wirth S, Syleouni ME, Karavasiloglou N, Rinaldi S, Korol D, Wanner M, et al. (2021). Incidence and mortality trends of thyroid cancer from 1980 to 2016. Swiss Med Wkly. 151: w30029. https://doi.org/10.4414/smw.2021.w30029 PMID: 34751539
  505. Yu EY, Wesselius A, Mehrkanoon S, Goosens M, Brinkman M, van den Brandt P, et al. (2021). Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study. BMC Med. 19(1): 56. https://doi.org/10.1186/s12916-021-01931-8 PMID: 33685459
  506. Zamora-Ros R, Lujan-Barroso L, Achaintre D, Franceschi S, Kyro C, Overvad K, et al. (2021). Blood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 113(1): 162-171. https://doi.org/10.1093/ajcn/nqaa277 PMID: 33021645
  507. Zhao LG, Li ZY, Feng GS, Ji XW, Tan YT, Li HL, et al. (2021). Tea Drinking and Risk of Cancer Incidence: A Meta-Analysis of Prospective Cohort Studies and Evidence Evaluation. Adv Nutr. 12(2): 402-412. https://doi.org/10.1093/advances/nmaa117 PMID: 33002099
  508. Zouiouich S, Loftfield E, Huybrechts I, Viallon V, Louca P, Vogtmann E, et al. (2021). Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies. Diabetologia. 64(8): 1749-1759. https://doi.org/10.1007/s00125-021-05464-w PMID: 34110438

 

 

 

 

Close Reading Mode
UP